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Abstract
Sickle cell disease is a genetic disorder that alters red blood cells such that their
hemoglobin cannot effectively bind and release oxygen. This causes issues that
affect how the cell operates in the smallest vessels of the body. In the past,
computational models have been used to study the microcirculation to gain a better
understanding of blood disorders such as sickle cell disease. A fast, time efficient
computational model has been developed to analyze perturbations in the
microcirculation caused by sickle cell disease. The model uses a finite difference,
Crank-Nicholson scheme for the flow and oxygen computation, while using the level
set computational method to advect the red blood cell membrane on a staggered
grid. A number of initial and boundary conditions were tested in the model. The
simulation data shows several important parameters to be significant in the
perturbation of the blood flow and oxygen concentration profiles. Specifically, the
Hill coefficient, arterial oxygen partial pressure, oxygen partial pressure at 50%
hemoglobin saturation, and cell membrane stiffness are significant factors.
Thesis Supervisor: Wesley L. Harris
Title: Professor of Aeronautics and Astronautics
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Symbols
x, y spatial coordinates
t time
v two dimensional velocity vector
p plasma density
p plasma pressure
y' plasma viscosity
u, v x & y velocity components
Vavg average RBC velocity
Dcap diameter of capillary
Rk capillary centerline to end of tissue length
R, capillary centerline to capillary wall length
Re Reynolds number for plasma flow
c oxygen concentration
DOX oxygen diffusion constant
D Hb diffusivity of hemoglobin
DMb diffusivity of myoglobin
R oxygen generation/consumption
R Hb oxygen generation inside the RBC by hemoglobin
R Mb oxygen consumption inside the tissue by myoglobin
Rplasma oxygen generation/consumption in plasma
M metabolic oxygen consumption in tissue
[Hb 4 08] concentration of oxyhemoglobin
[Hb4] concentration of deoxyhemoglobin
[Mb02] concentration of oxymyoglobin
[Mb] concentration of deoxymyoglobin
[H b4]tot concentration of total hemoglobin
[Mb]tot concentration of total myoglobin
Hb hemoglobin dissociation rate constant
k"? myoglobin dissociation rate constant
k1 hemoglobin association rate constant
kfH' myoglobin association rate constant
KMb hemoglobin equilibrium constant
Keqb myoglobin equilibrium constantH-b
Hb oxygen concentration at 50% hemoglobin saturation
Mb oxygen concentration at 50% myoglobin saturation
p5H0b oxygen partial pressure at 50% hemoglobin
Mb
P50% oxygen partial pressure at 50% myoglobin
SHb hemoglobin saturation
SMb myoglobin saturation
n Hill coefficient
U, V x & y velocity components in computational domain
P pressure in computational domain
h discrete spatial grid length
# level set function
F magnitude of velocity
n velocity unit vector
fl level set domain
a pressure jump across membrane
J jump matrix, containing all pressure jump values
Po2  partial pressure of oxygen
a- red blood cell membrane stress
K red blood cell membrane curvature
kRBC red blood cell membrane stiffness
i,j reference spatial indices
n reference timestep
a Henry's Law constant
i stiffness index
a semi-major axis
b semi-minor axis
1 Introduction
Sickle cell disease is a genetic blood disorder which degrades the oxygen carrying
capacity of a Red Blood Cell (RBC). Sickle cell disease affects the entire body
because reduced oxygen in the blood leads to lower oxygen in vital tissues and
organs throughout the body, leading to hypoxia and acute pain. Individuals with
sickle cell disease are expected to live only into their mid 40s. [ 1 1 Not only is the
life expectancy shortened, but the quality of life is also extremely diminished.
Affected individuals must be careful so as not to cause the onset of a crisis, which
involves extremely painful acute pain, usually in the extremities. This generally
involves avoiding rigorous physical activity, staying well hydrated, maintaining a
healthy diet, and avoiding low-oxygen atmospheres (aircrafts, high elevations, etc.).
1.1 Genetics and Pathophysiology of Sickle Cell
Sickle cell disease is caused by a hereditary mutation in a gene causing altered
hemoglobin proteins in the erythrocytes. As blood is pumped from the heart
through the lungs, oxygen molecules bind to the hemoglobin creating a complex
called oxyhemoglobin. The oxygen breaks its bond with the hemoglobin and
diffuses through the RBC membrane to the tissue, providing the body with oxygen.
The unbound hemoglobin molecules are then referred to as deoxyhemoglobin. A
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healthy adult erythrocyte contains the hemoglobin A (HbA) protein within its
cytoplasm; however a sickle RBC contains sickle hemoglobin, the hemoglobin S
(HbS) protein. An HbA molecule contains two a-chains and two p-chains as shown
in Figure 1.1. The genetic mutation in HbS causes a change in the p-chains, replacing
a hydrophilic amino acid with a hydrophobic amino acid, thus changing the binding
affinity between hemoglobin molecules. The increased binding affinity between
HbS molecules results in anemia, or decreased binding of oxygen molecules. Under
conditions of low oxygen concentration, there is a far greater probability of the HbS
molecules bonding to each other.
Hemogobn A iemok*n S
0o"02 
Oh20 02
02" 02 02" 0D Oxyhemoglobin under high [02]
02 02
02"0 2 2
Deoxyhemoglobin under low [02]
02
02 02
Figure 1.1 - Oxyhemoglobin and Deoxyhemoglobin A & S [ 2 ]
The Pink circles represent hemoglobin a-chains; the blue and green represent the
HbA and HbS p-chains respectively. The HbS protein molecules polymerize under
low oxygen conditions, forming long chains.
(Source: http://www.bio.davidson.edu/people/midorcas/animalphysiology/
websites/2005/Eppolito/)
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Sickle cell primarily affects populations from tropical and subtropical regions that
are heavily stricken by malaria. Highest concentrations of sickle cell are found in
Africa, the Mediterranean, India, and the Middle East. In the United States, nearly
85% of all sickle cell cases presented are found in people of African descent. [ 2 1
Figure 1.2 shows a comparison between malaria stricken regions and areas of high
concentrations of sickle cell disease in Africa. This correlation is due to the fact that
individuals with sickle cell disease are resistant to Plasmodium falciparum, the
parasite that causes malaria. Typically, malaria is acquired when a mosquito
carrying the parasite bites a human. The parasite travels through the bloodstream
to the liver, infecting erythrocytes and liver cells (hepatocytes). Healthy RBCs have
a lifespan of 90 to 120 days, whereas a sickle cell only lives 10 to 20 days. In a
healthy erythrocyte, the parasite will typically survive long enough to reproduce;
however, in a sickle erythrocyte the cell will die before the parasite undergoes
reproduction. [3 ]
Figure 1.2 - Distribution of Sickle Cell gene and Malaria parasite
(source: http://images.encarta.msn.com)
Sickle cell is an evolutionary advantage in humans to protect from malaria. Humans
have two sets of all genes; therefore there are two sickle cell genes. Individuals with
one HbS gene, and one HbA gene, are said to be carriers of the sickle cell trait. A
fraction of their erythrocytes will be sickle, but not enough to result in anemia or
other sickle cell disease symptoms, but enough such that the malaria parasite
cannot reproduce effectively enough to thrive. An individual having two HbS genes
will have all sickle erythrocytes and suffer from the disease. Therefore an individual
with only one HbS gene has an advantage because they are both resistant to malaria,
and they do not exhibit the disease symptoms.
- 1111111111", ............... . . .. .. ....... ...........
1.2 Blood Flow Dynamics
In the human body, blood is pumped from the lungs to the rest of the body, moving
from the large arteries, to smaller arteries, then finally into the smallest capillaries.
In the larger arteries, both healthy and sickle erythrocytes are free to flow in groups
without altering their natural shapes. The internal diameter of a capillary is roughly
8ptm; whereas the erythrocyte diameter at rest is about 10km. The erythrocytes
must flow single-file and squeeze into a "bullet-like" shape as they pass through
these narrow passages. [ 4]
For individuals with sickle hemoglobin, this process is slightly different.
Throughout this process, the sickle cells are releasing oxygen and the hemoglobin
molecules are beginning to polymerize, forming branching chains. Over time, the
erythrocytes will continue to diffuse oxygen and the hemoglobin will continue to
polymerize, forming longer and longer fibers until they begin to affect the shape of
the cell. The membrane begins to stiffen and take the shape of the fibers. Figure 1.3
and Figure 1.4 show the HbS polymerization and the sickle erythrocyte shape.
The sickle erythrocytes have stiff membranes and are not flexible enough to flow
smoothly within the capillaries. They can become stuck in the capillary causing a
vaso-occlusion. The occlusion prevents the flow of blood and thus oxygen to the
tissue downstream, causing ischemia, pain and restricted oxygen to tissue. In some
cases a sufficient number of vessels are occluded, causing organ damage or even
19
failure. This phenomenon is known as a vaso-occlusive crisis. Vaso-occlusive crises
are extremely painful and unpredictable events. This unpredictability makes it very
difficult to manage.
Figure 1.3 - Normal vs. Sickle RBC
The sickle cell takes the shape of the
polymerized hemoglobin.
i 20
Typical rults of two-dimesioma simulation. b - 0.06 do-
flecdos per polymer per secg 6 X 10-' mudention eenms per inor-
porated monomer per second, and -0.11 pm/s. As can be seen, he domain
giows longer and wider. Because of the random cwvaoure of the polymer,
the psueis nwe generully skewed to one side or the other. The number of
mosomers polymerized in a typia smuladon is sabout 106
Figure 1.4 - HbS Polymerization
This model illustrates the
polymerization of HbS over time. [5 ]
t=9.5 (sec)
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1.1 Current Treatment
At the moment, there is no cure for sickle cell disease. Affected individuals must live
with this illness for their entire life. There are treatments that aim to treat the
symptoms of the disease and prevent the onset of crises; however, none of these
treatments are completely effective in all sickle cell patients.
Drug therapies include anti-sickling drugs such as Hemoxin and Hydroxyurea.
These drugs prevent the erythrocytes from sickling by triggering the production of
fetal hemoglobin (HbF). [ 6 ] Fetal hemoglobin is produced by the body during the
prenatal and infancy period, but is stopped around 18 to 24 weeks after birth. [ 7 ]
HbF does not polymerize and will not cause the blood cell to sickle. Unfortunately,
the long-term effects of these drugs are unclear. Sickle cell crises are typically
treated symptomatically. Patients are treated with pure oxygen to stop hypoxia and
opioids to manage the pain. Blood transfusions can also be carried out to resupply
the body with healthy HbA carrying erythrocytes.
There are some promising remedies that are undergoing testing. Bone marrow
transplants have been shown to be effective among children. It is believed that
healthy transplanted bone marrow can produce healthy erythrocytes; however, the
complications from a bone marrow transplant can be life-threatening.
1.2 Previous Blood Flow Models
A properly functioning blood microcirculation system is critical to the health of
humans. There exist several macro-level models of the fluid dynamics of the blood
microcirculation system. These models have provided useful information and an
improved understanding of the blood microcirculation system. However, these
models do not include some analytical details corresponding to a critical
microscopic description of the physical, dynamical, and chemical diffusion, which
are necessary to predict the behavior of some diseases such as sickle cell anemia.
These models are based on empirical results combined with simplified physical
descriptions that often neglect the microscopic complexity of blood cell structure
and oxygen transport through the blood cell membrane into the surrounding tissue.
Specific numerical methods and empirical results have advanced sufficiently to the
point where more realistic models of the blood microcirculation systems may be
developed.
The Le Floch-Harris [ 8 ] model is a novel methodology, developed to address sickle
cell disease, based on highly descriptive mathematical models for blood flow in the
capillaries. The investigations focus on the coupling between oxygen delivery and
red blood cell dynamics, which is crucial to understanding sickle cell crises and is
unique to this blood disease. The model entails an extensive study of blood
dynamics through simulations of red cells deforming within the capillary vessels,
and relies on the use of a system of equations describing oxygen transfer, blood
plasma dynamics and red cell membrane deformation mechanics.
The Le Floch-Harris model aims to achieve an improved understanding of the
complex interaction and interdependence of blood plasma dynamics, red blood cell
membrane deformation, and oxygen transport from the red blood cells to the
surrounding tissue. A physically plausible model of this complex interaction and
interdependent state of the blood microcirculation constitutes the first product of
the proposed coupled, multi-scale numerical simulation. The results/models are
expected to lead to the development of new research strategies for sickle cell
disease. The Le Floch-Harris simulation models could be used not only to assess
current researched remedies, but also to spur innovative research initiatives, based
on the study of the physical properties coupled in sickle cell disease.
The Le Floch-Harris model uses a 5-layer model which incorporates the following 5
domains: RBC cytoplasm, blood plasma, endothelium (capillary wall), the
interstitium (space between the capillary vessel and the surrounding tissue). [ 8 ]
Le Floch's model assumes constant radius, circular cross section along the length of
the capillary. This assumption allows the approximation of the flow as being a 3-D,
axially symmetric flow. The erythrocytes are assumed to be symmetric about the
centerline.
1.3 Mathematical Model
The primary objective this research is to create a simplified mathematical model of
the healthy and sickle microcirculation in the capillary and surrounding tissue. This
model would serve as a proof of concept for a simplistic model that can demonstrate
similar results to more complex models such as the Le Floch-Harris model. The
results will be compared to those of more complex models to either validate or
refute it. If indeed, our model is shown to have merit, it can then serve as a first
order approximation for more complicated models, saving time and providing some
indication of the specific ranges of parameters that might lead to crisis within
individuals with sickle cell disease.
We will begin with the following set of governing fluid dynamics equations for our
system: (1) the continuity equation, (2) Navier-Stokes equation, and (3) Fick's Law
of mass diffusion, which we will refer to as the oxygen diffusion equation.
V-=0 , (1.1)
a Vp + V -Vv)= Vp + yV 2 v, (1.2)
+ V - (cv - DxVc) = R(c) , (1.3)
Our unknown field quantities are v, the velocity vector field, c, the oxygen
concentration field, and p, the pressure field. R represents the oxygen
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generation/consumption function which is a function of oxygen concentration and
will be explained later.
The flow of the blood within the capillary is completely characterized by these
governing equations and is constrained by the boundary and initial conditions of the
flow. A no-slip/no-flux condition will be used for the plasma at the capillary wall
while periodic boundary conditions are used at the inlet and outlet. The oxygen
concentration will use Neumann boundary conditions at the tissue boundaries. The
initial conditions will be constant field values everywhere for the oxygen
concentration and velocity field. These initial and boundary conditions will be
discussed in further detail in chapter 2.
Our flow equations represent a flow in two dimensions, using a Cartesian coordinate
system. For simplicity, we will approximate the three dimensional axial capillary
flow and oxygen diffusion as a two dimensional flow between two long, parallel, flat
plates. The healthy microcirculation flow will represent a mean, baseline flow.
Perturbations in the flow parameters and cell membrane characteristics will be
introduced to model the sickle nature of the RBC and plasma flow.
We seek to show that the simplified, two dimensional system of equations will
produce results comparable to results determined computationally from the set of
nonlinear partial differential equations. From our solutions, we will be able to
characterize and identify the physiological parameters that can be modified,
changing the flow dynamics to produce more favorable outcomes in the blood flow.
There will be some degree of uncertainty due to the nonlinearities in the governing
equations. If we can show that these nonlinearities produce small or negligible
results for the physiological parameters within the boundaries of the human
tolerance, we will have proved that a simpler, less computationally expensive
method can yield similar results. If however, we cannot show that the effects of the
nonlinear terms are small, we will be able to show that the nonlinear terms play a
large role in the physics of the blood flow, meaning that even small perturbations
may have large, resounding effects. This may open up the discussion of the
involvement of chaos in fluid dynamics during the onset of crisis.
2 Microcirculation Model
2.1 Physical System
The general hemodynamics of the microcirculation includes the arterioles,
capillaries, and venules. Our particular area of interest is within the smallest blood
vessels of the circulatory system, the capillaries. As oxygen rich erythrocytes enter
the capillaries from the arterioles, oxygen molecules are unbound from the
oxyhemoglobin complexes. The hemoglobin molecules continue to release oxygen
as the erythrocyte traverses axially along the capillary and into the venules. In the
sickle case, the erythrocyte membrane stiffness will increase as the hemoglobin
saturation decreases due to the hemoglobin polymerization phenomenon.
The heart comprises four chambers surrounded by cardiac smooth muscle. The
cardiac muscle contracts around these chambers to pump blood into the lungs and
throughout the body. Oxygen rich blood is carried from the left ventricle of the
heart, downstream into the smaller vessels to deliver oxygen and other nutrients to
tissue throughout the body. The periodic contraction of the left ventricle causes the
blood pressure to vary in time creating pulsating oscillations. These oscillations can
be seen in Figure 2.1.
The blood leaves the left ventricle, entering the aorta, the largest artery in the body.
From the aorta, the blood travels into smaller arteries, which then branch into
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several arterioles and eventually millions of capillaries. [ 9 ] Although a capillary
has a much smaller cross section than the aorta, the total cross sectional area of all
capillaries is orders of magnitude larger, thereby reducing the flow velocity and
greatly dampening the oscillations in pressure.
Systernic Circulation
Figure 2.1 - Systemic Circulation Pressure
Pressure oscillations are dampened out by
the time the blood reaches the capillaries. [
10]
The plasma flow is driven by the beating of the heart. In the capillary, the flow
pressure drops about 20mmHg (2666 Pa) across an average length of 8mm. This
yields a pressure gradient in the capillary of, d = 3.33 x 10s a. [ 10 ] Thisdx m
calculated value is consistent with the Le Floch-Harris model value ofdx
3.3 05a m 1
..... . ....... ... . ........
In addition to erythrocytes, the blood also contains many other components. In
addition to oxygen delivery, the circulatory system serves as the delivery pathway
for the leukocytes and platelets. The relative amount of erythrocytes in blood is
defined by the hematocrit. The hematocrit is a ratio of red cell volume to total blood
volume. In healthy adult humans, the hematocrit is roughly 0.45 which means that
about 45% of blood is RBC by volume. About 55% of blood volume is plasma. [ 11 ]
Therefore, blood volume of leukocytes and platelets is less than 1%. By this
rationale, we will assume that our capillary flow model contains only plasma and
erythrocytes.
To accurately capture the dynamics of the oxygen diffusion and plasma flow, it is
critical that we appropriately model the physical system by defining the boundary
conditions at every interface. The capillary flow model must comprise the contents
within the capillary as well as the capillary wall itself in addition to the surrounding
tissue. The plasma and RBCs do not cross through the capillary walls; however the
oxygen molecules will diffuse into the surrounding tissue.
First we determine the specific regions or "layers" in our model. In the Vadapalli,
Goldman, and Popel [ 12 ] 5-layer model, the interstitium and vascular wall are
accounted for in addition to the RBC cytoplasm, blood plasma, and tissue. The
relative thicknesses of each of the regions are shown in Table 2.1. As illustrated in
Figure 2.2 and Table 2.1, the interstitium and vascular wall layers are very thin in
comparison to the other regions.
Table 2.1 - Relative Thickness of Regions
Region Thickness [m] % Thickness
Plasma
Endothelium
Interstitium
Tissue
3.5E-6
0.30E-6
0.35E-6
15.9E-6
17.5%
1.5%
1.7%
79.3%
The oxygen consumption rates in the smallest regions, the endothelium and
interstitium, are small in comparison to that of the tissue. Due to small size and low
oxygen consumption rates, these two regions will be neglected in our calculations.
We will instead use a 3-layer representation for our model.
Figure 2.2 - 5-Layer and 3-Layer Models
In addition to the RBC, plasma and tissue, the 5-layer
model also incorporates the interstitial space and the
vascular wall, which are both very thin.
In reality, the blood flow in the capillary is not absolutely axially symmetric. Small
oscillations in the flow due to fluctuations in the flow speed, pressure variations,
and changes in the capillary wall radius or curvature can cause the flow to be non-
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symmetric, leading to tangential velocity components and unexpected radial and
axial flow profiles.
In order to simplify the three dimensional nature of our system, we will assume that
these small oscillations are negligible. Unlike the Le Floch or the Krogh cylinder
model, we will assume vertically symmetric flow between two, long, flat plates
instead of a three dimensional axisymmetric flow. This representation can then be
modeled as a two dimensional flow on a rectangular domain.
The plasma flow is governed by the incompressible Navier-Stokes and continuity
equations. Applying constraints of two dimensional Cartesian coordinates, and
separating the Navier-Stokes equation into its components, equations (1.1) and
(1.2) become,
ux + Vy = 0 ,
p(ut + uu, + vuY) = -Px + p(uxX + u y,)
P(Vt + uvX + vvy3) = -Py + P(VXX + vyy)
(2.1)
(2.2)
(2.3)
The plasma flow boundary conditions applied are no-slip/no-flux at the capillary
wall, and periodicity at the entrance and exit of the channel.
Ewalt = 0 ,( (2.4)
Etentrance = Yexit , (2.5)
The RBC serves as the oxygen delivery vehicle for the body, delivering fresh oxygen
from the lungs throughout the body via the circulatory system. At the level of the
capillary, the oxygen diffuses through the RBC membrane, through the plasma and
into the tissue. At the same time, the tissue is consuming the oxygen by binding the
oxygen molecules to the myoglobin complexes, thereby reducing the concentration
of oxygen in the tissue. Therefore, we can model the moving RBC as an oxygen
source and the tissue as an oxygen sink.
Within the RBC cytoplasm there are several organelles, however our only interest is
in the hemoglobin protein because it makes up 97% of the entire RBC dry content [
9 ] and it directly influences the oxygen production rate. Therefore, we will only
model the hemoglobin within the RBC and assume it is evenly distributed
throughout the cytoplasm. Similarly, the myoglobin is considered to be evenly
distributed throughout the tissue. Furthermore, we will assume that oxygen can
diffuse freely from the RBC cytoplasm through the cell membrane and into the
tissue.
The plasma and RBC are in motion while oxygen is diffusing through the layers;
however we assume there is no moving fluid in the tissue. Our oxygen transport
must have an advection term to account for the fluid flow in the capillary.
Simplifying equation (1.3) by applying 2D Cartesian coordinates, and the constraint
of continuity, we obtain equation (2.6).
(2.6)
(2.7)
The oxygen generation/consumption function, , represents the rate at which
oxygen is produced, therefore it can be calculated as the oxygen concentration time
derivative, must be calculated at each layer of our model. These can
rates can be derived from the chemical kinetics of the oxygen-hemoglobin and
oxygen-myoglobin association reactions.
Hb 4 + 40, k Hb 4 08'
-1
(2.8)
(2.9)
Mb + 0., Mbov'
oil
(2.10)
(2.11)
, also written as , is the oxygen concentration field. and are forward
are the kinetic dissociation raterate reaction constants, while and
constants, or the kinetic reaction rate constants for the reverse reactions. KHb and
Keqbare the equilibrium constants. Using these equations, RHb and RMb can be
derived.
RHb - 4ki [H b4 0] - 4k+b [H b4 ]c4dt chem =4_ H48 1 4
RMb = - Mb k_"[MbO 2 ] - kf"'[Mb]ct chem
(2.12)
(2.13)
As mentioned in chapter 1, the hemoglobin protein is a tetramer containing two a-
chains and two -chains, each of which includes an oxygen-binding heme group.
This allows each hemoglobin protein to bind four oxygen molecules. Conversely,
each myoglobin protein contains only one heme group, limiting it to binding only
one oxygen molecule.
Figure 2.3 - Hemoglobin and Myoglobin Saturation Curves
The cooperative binding properties of hemoglobin lead to
a stronger affinity for oxygen than that of myoglobin. The
Hemoglobin curve is accurate above 1kPa.
At 50% saturation, equations (2.9) and (2.11) become
k Hb
(C Hb)4 = ( = Ke1 (2.15)k+1
kMb'csMb/ = M (K41 (2.15)
k+1
Saturation is defined as,
SHb - [Hb4 0 8  (2.16)[Hb4]tot
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In the cell cytoplasm, R = RHb. Free oxygen is produced as the oxyhemoglobin
complex unbinds, releasing oxygen; therefore, RHb is a function of the local
hemoglobin saturation. In the plasma, oxygen is neither consumed nor produced
and the function is zero in this region. In the tissue, R depends on the rate at which
oxygen is consumed by binding to the myoglobin, RMb, in addition the constant
consumption rate of the tissue, M, due to general metabolic activities.
RHb c Hb C n
Rh Hb- [Hb] J _ (2.18)
chem C50%
OCplasma
Rplasma - 0 ,plam , (2.19)
at chem
RMb - - kMb Mb -(1- sMb) Mb
chem ( (C%))
[Hb] and [Mb] are the concentration of hemoglobin subunits inside the RBC and the
concentration of myoglobin in the tissue respectively. n is the Hill coefficient, which
is an empirically found value. Finally, R is then given by the sum of values in each
region from equation (2.7),
c
R = ki [Hb] SHb - (1 - SHb) Hb )
C50%
(2.21)
+ kMb[Mb] SMb - (1 - SMb) M + M
C50%
Each of the quantities in equation (2.21) are known constants in each region with
the exception of the oxygen concentration, which we are solving for, and the
hemoglobin and myoglobin saturation values, which are functions of oxygen
concentration. By the principle of conservation, the total number of hemoglobin
proteins and myoglobin proteins in the system do not change.
To calculate the hemoglobin and myoglobin saturation values, we use a similar
diffusion analysis. Looking at the diffusion of the saturation of hemoglobin and
myoglobin, we obtain equations similar to equation (2.6).
SIb + uSHb + VSHb 
Rb(SxHb 4ZHb [Hb
. t X -D x(S +S?) [Hb] (2.22)
+ +b Sb b ~DMb(S~b +Qb) RMb
St + uS + vSy - D (x"yb [Mb] (2.23)
Substituting equations (2.18) and (2.20), we get
SeHb + uSHb SYH b - Db(SxHb + SHb)
= -k ( SHb - (1 - SHb)
SeMb + uSMb + vsyMb - Db(Sbx + Syyb)
b M(2.25)
= -k_1 Mb
Using equations (2.6), (2.21), (2.24), and (2.25), we can completely define the
oxygen concentration and rate of oxygen diffusion everywhere in the system.
2.2 Computational Model
The computational model for the capillary flow was constructed using Matlab@
software. The blood plasma flow and oxygen concentration calculations are solved
using a finite difference method on a static, staggered, Marker-and-Cell (MAC) grid.
The finite difference scheme used to solve the blood plasma flow conditions is based
on a Navier-Stokes solver [ 13 ] developed by Benjamin Seibold of the Mathematics
Department at MIT. The plasma and RBC membrane interactions are implemented
using the level set method. [ 141
Table 2.2 - Plasma Flow Parameters
Parameter Value
p
Vavg
Dcap
It
Re = PVavgDcap
p
1025 g3
10-1 M
S
8 x10- 6m
1.5 x10- 3 Pa -s
5.47 x 10-3
A Cartesian coordinate system is used because the physical system is approximated
as a 2D plasma flow on a rectangular surface, as shown in Figure 2.2. The RBC is
modeled as an elastic membrane with a bending stiffness kRBC. The properties of
the blood flow and RBC membrane are listed in Table 2.2.
2.2.1 Blood Plasma Flow
The compactness and efficiency of Seibold's method results from the fixed geometry
and static discritization of the grid in time. Therefore, the system matrices are the
same at each time step and need to be computed only once. [ 13]
The blood plasma follows the 2D incompressible Navier-Stokes equations, (2.2) and
(2.3), and is constrained by the incompressible 2D mass continuity, equation (2.1).
The dimensionless, scalar component versions of these equations are shown below.
u+v, = 0 , (2.26)
1
Ut = -(u) - (uv), + -(uxx + uyy) -px , (2.27)
1
Vt = - -uv), (v 2 )y + _ + vYY) py , (2.28)
The time step updates for velocity components U' and V' will be computed in a
series of steps, by incorporating each term in the Navier-Stokes equations. First, we
will incorporate the nonlinear advective terms from equation (2.27), [-(u 2)x -
(uv)y], and equation (2.28), [-(uv)x - (v 2 ),]. The first updated values of velocity
will be denoted as U* and V*. These values are solved explicitly using an upwinding
scheme as shown in equations (2.29) and (2.30).
Ut = 
-((U)2 _ (U"Vn), , (2.29)
V* = -(U"V4), 2)y (2.30)
At
Next we update velocity by incorporating the viscosity terms, -(ux + U and
[(vxx + vyy)j, implicitly.
U U*
At (2.31)
(2.32)* -V Vxx* + VAt Re (xx yy),
Finally, we can update the velocity by including the pressure terms, [-px] and
[-Py], implicitly.
Un+1 - U**
At
Vn+1 - V**
.- (Pn+1)x ,
-(pn+l)y 
,
(2.33)
(2.34)
Equations (2.33) and (2.34) can be rewritten in vector form as,
Un+1 -U**
-. - = -vPn+1 (2.35)
The pressure is found by computing the divergence of both sides, which eliminates
the Un+1 term due to the continuity constraint, and you are left with
- = -APn+1
At (2.36)
-( *x+ U*) ,
Applying the inverse Laplacian operator to equation (2.36) then gives the pressure
at the new time step (Pn+1). Finally, we can take the gradient of the pressure field
to obtain the velocities.
Gn*1 = -VPn+, (2.37)
Un+1 = U** + AtGn+1 , (2.38)
As mentioned previously, the efficiency of these calculations is in large part due to
having calculated the system matrices only once before marching through the finite
difference scheme. The system matrices for our system are essentially inverse
Laplacian operators. These system matrices are implemented using the Crank-
Nicolson scheme, which is second-order accurate in time and space.
2.2.1.1 Spatial and Time Discritization
The advection term calculation above uses a centered difference scheme, which is
second order accurate as opposed to a forward or backward difference scheme.
Despite the higher order of accuracy, using a centered difference scheme can create
oscillations due to the coupling of the variables because they are all calculated at the
same points. To eliminate this phenomenon, we use a staggered grid. [ 13 ]
x x x x x
X X X X X 
U XP x x x x
Figure 2.4 - Staggered MAC Grid
Interior cells are shown in black and
boundary cells are shown in gray. Crosses
denote cell centers where fluid pressure
and other quantities are calculated. The
circles denote the cell borders where
velocity components are calculated (U-
velocity in filled circles and V-velocity in
unfilled circles)
Consider a rectangular domain, which is discretized into rectangular elements on a
staggered grid. In this grid, the velocities are defined on the boundaries and the
pressures are defined in the centers of the cell as shown in Figure 2.4.
For our solution to converge with stability, we must satisfy the Courant-Friedrichs-
Lewy (CFL) condition. The limiting time step will be for the explicit upwind
calculation of the advection terms. The diffusion terms are calculated using a
second-order accurate, Crank-Nicolson scheme which is unconditionally stable. [ 15
] Therefore, to ensure overall stability, the following conditions must hold true.
1OPP41"Wr ___ -- - _=_ 12
CFL condition for advective term:
At At
Umax+t+ ax - 1A (2.39)
The horizontal and vertical grid sizes are the same; Ax = Ay = h, therefore,
At
(Umax + Vmax) - 1 , (2.40)h
At (Umax + Vmax) (2.41)
We desire a time step as large as possible to reduce computational time for the
simulation, but small enough to ensure stability. Equation (2.41) shows that the
maximum time step is related to the grid spacing and maximum speed of the flow
within the capillary, which changes in time. Instead of choosing a new time step at
each iteration, we can choose a time step small enough such that it always satisfy
the CFL condition.
Since we are using non-dimensional equations for our model, all quantities are
relative and the actual values are meaningless before they are dimensionalized. By
design, we can set the initial velocity at all points within the flow to unity, and the
maximum velocity should not exceed this value by much more. Test cases of the
model with very small time steps have shown that the maximum velocity does not
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exceed three. For total certainty, we will use the value of four for the maximum
velocity.
Next, we must calculate the grid size. All of our equations have been non-
dimensionalized using the capillary diameter as a reference length. Therefore the
diameter of the capillary will be set to unity and all other values will be
proportional. The length of our channel will be set to be a multiple of the diameter.
South
Tissue
Figure 2.5 - Computational domain in 3-Layer Model
Coordinate axes at the center of the computational domain
Based on computational time and accuracy, the optimal grid step size is determined
to be . Using equation (2.41) and the values determined for grid step size
................ I  . ......
and maximum velocity, the time step is calculated, At = 0.0050. Test simulations
however, show much smoother results for a lower time step of At = 0.0025,
therefore we will be using this value.
For our flow calculations, it is important that we can calculate velocities, pressures,
and their derivatives at the same points. We can find these values at neighboring
locations by averaging or by finding first or second differences for the derivatives.
2.2.1.2 Flow Boundaries
The flow is bounded by two other regions. The first, on the north and south
boundaries, is the capillary wall. At the capillary wall, the plasma velocity is zero
because we impose a no slip / no flux condition. The east and west border of the
computational domain are set to be periodic. The flow velocities and pressure
gradient are also periodic such that the flow properties are continuous on the east
and west boundaries of the capillary channel.
Y-N Y-S= 0(2.42)
EEs = Ew , (2.43)
The second boundary is the RBC membrane. The flow properties for this boundary
and inside the RBC will be discussed in the next section.
2.2.2 RBC Membrane
The level set method is used to dictate the advection of the RBC membrane. A
function #(x,y) is produced in the mesh space such that #(x,y) = 0 defines the
boundary between the cell and the plasma. The domain inside the boundary, f-, is
defined by #(x,y) < 0, and the domain outside the boundary, fl', is defined by
#(x, y) > 0. Our zero level set function is initially approximated as an ellipse with
the semi-major axis along the diameter of the capillary and the semi-minor axis
along the axis of the capillary.
The rate at which the level set function propagates depends on the flow speed. This
propagation will follow the convection equation:
#t+v- #= 0 ,(2.44)
By definition, the gradient of the level set function is parallel to the velocity vector.
Therefore, we can rewrite our velocity vector as the product of the magnitude of the
velocity, F, and unit vector in the direction of the level set function, --. Substituting
these quantities into equation (2.44) yields the level set function.
#t + FIV#I = 0 , (2.45)
In order to determine F, the propagation rate, we can use the dot product of the
velocity and gradient of the level set:
v -V# = Fn - V#, (2.46)
(u, v) - (#, # = F V# , (2.47)|v#|
uPx + vby = FIV#| , (2.48)
uqx + v(y = F , (2.49)
u _x + 4)Y#
F = qx , (2.50)
The propagation rate, F, is calculated at each iteration, and as shown in equation
(2.50), F is dependent on the plasma flow velocity. For greater accuracy, the level
set function is moved onto a finer mesh and propagated on this grid at a
proportionally smaller time step. It is then returned to the original, coarser mesh.
This allows us to have a more accurate advection scheme while saving time by
running the rest of the simulation at such a coarser mesh.
The fluid both inside and outside the RBC are governed by the Navier-Stokes
equations, however, the RBC membrane acts on the fluid as an additional body force.
Unlike the capillary wall, the RBC membrane does not have a no-slip condition. In
our computational model, the flow is discontinuous at the boundary due to the
reactionary body force of the membrane acting on the cytoplasm. These membrane
stresses on the fluid can be expressed as a jump in pressure across the fluid;
therefore, they can be incorporated into the Navier-Stokes calculations of the
plasma flow. This pressure jump must be accounted for when calculating the
pressure of a fluid element that accesses a pressure of a neighboring cell that is on
the opposite side of the membrane.
Figure 2.6 - Jump condition at RBC boundary
Jump conditions and are shown on a 5-point
stencil. Jump conditions are applied for points on the
stencil that lie in a different domain than the center
point.
Figure 2.6 illustrates an example of a point (i,j) which has two points in its stencil
on the opposite side of the level set boundary. The stencil for the 2nd difference of
the pressure would be written as
1 1
2 (Pi-1,1 - 2pij + pi+1,j) + 2(Pi-1, - 2pi, + pi+1,j)(hx) 2(hy)
(2.51)
= f +R (hX)z 2(hy)2
The aR and aT terms account for the pressure jump, across the boundary for the
right-hand (i + 1,J) and top (i,j + 1) points respectively, caused by the stress
applied on the fluid by the RBC membrane. Notice that there are no additional
terms for the left-hand (i - 1,J) or bottom (i,j - 1) points because there are on the
same side of the boundary as the center point (i,j) on the stencil.
RBC membrane stiffness is a uniform value across the membrane, but varies for
healthy and sickle erythrocytes. We use a value of kRBC = 1.9 X 10~5 N for healthym
erythrocytes. [ 16 ] In sickle erythrocytes, the membrane stiffness is dependent on
local oxygen concentration. As the oxygen diffuses out of the cell, the
oxyhemoglobin complexes are unbound, producing free oxygen and consequently,
change their molecular conformation, leaving them vulnerable to polymerization in
the sickle case. Although my model does not directly simulate the polymerization of
HbS and its affect on the RBC shape, this model does capture the increase in cell
membrane rigidity for the oxygen-reduced sickle RBC.
Berger and King propose an inverse exponential relationship between stiffness and
oxygen concentration.
kRBC 
__ C 
_P02O (2.52)
(kRBC) 0 C0 (pOz 0O)-
In equation (2.52), (kRBC)o represents the stiffness of a normal cell; c0 and (p 2 ) 0
represent the oxygen concentration and oxygen partial pressure when the cell is
fully oxygenated at the arterial end of the capillary. The stiffness index, j, is a
positive constant. Berger and King use data from an experiment conducted by
Usami et. al., to justify the stiffness index value. Figure 2.7 shows the non-
dimensional resistance, which we refer to as kRBC plotted against the oxygen(kRBC)o' potdaantteoye
partial pressure in both linear and log-log axes. Based on these plots, it appears that
a stiffness index of j = 2 is reasonable. Based on the slope from the best-fit line on
the logarithmic plot, it appears that a stiffness index of j = 2 is reasonable value.
P (mmHg)
Figure 2.7 - RBC Membrane Stiffness vs. 02 Partial Pressure [ 18]
Membrane stiffness for healthy and sickle RBCs are plotted on linear and
log-log plots. The plots indicate an exponential relationship between
membrane stiffness and 02 partial pressure for sickle RBCs, and no change
in membrane stiffness for healthy RBCs.
This value, however, serves as an upper bound for the stiffness index because in the
experiment, the sickle blood was "allowed sufficient time to equilibrate with the
oxygen tension" [ 17 ]. Therefore, the stiffness index will vary in the range
The membrane stress is calculated as the product of the membrane stiffness and the
curvature of the membrane.
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02
a' =kRBCK , (2.53)
where the curvature, K, is calculated from the level set function,
-2 OYp + py2
K= (pOXp3 ' (2.54)
This is another simplification in our model. Creating a stress function that is directly
proportional to curvature assumes that at rest, the membrane would take the shape
of a circle, the shape that would minimize overall stress on the object. However in
reality, at rest, the RBC has a bi-concave shape. As the fluid within and exterior to
the cell moves, it will deform the RBC, causing different stress levels on the cell
membrane.
This could have some impact on the results of this simulation, by creating the
appearance of higher stress values at the points of greatest curvature. Additionally,
this model might slightly decrease the apparent surface area of the RBC, which could
impact the velocity profiles. This would not impact the oxygen diffusion however,
because the diffusion calculations are dependent on the volume of the RBC, not the
surface area, which is controlled to remain unchanging with each time step.
The membrane stress at each point adjacent to the membrane is calculated to
account for the total pressure jump. These values are summed into a matrix, J,
which is then added to the pressure term when P"' is calculated.
2.2.3 Oxygen Diffusion
The oxygen diffusion is incorporated into our computational model, allowing us to
observe the oxygen concentration throughout the system as the RBC traverses the
capillary. The oxygen diffusion component must model the oxygen-hemoglobin
interaction, oxygen diffusion throughout the RBC, plasma, and tissue, the oxygen-
myoglobin interaction (binding of free oxygen), and the consumption of free oxygen.
Like the fluid pressure, the oxygen concentration will be calculated at the cell
centers in our computational grid. Therefore, all saturation values, flow velocities
and oxygen concentration derivatives must be averaged or differenced to provide
values at the cell centers as well. Equation (2.6) is rewritten in the computational
domain as
Cn+1 - Cn
At + UC +VC - Dx(Cx + C) = R(C) , (2.55)
The first spatial derivative of the oxygen concentration is calculated using an explicit
centered difference scheme. The second spatial derivatives are derived using an
implicit Crank-Nicolson scheme. The oxygen concentration update can then be
calculated as,
Cn+1 = C" + At[R(C") - U"Cx" -V"C,"
(2.56)
+ x D(Cxnx + Cy,Y|]
SHb and SMb updates are calculated in a similar fashion. Equations (2.24) and
(2.25) in the computational domain are written as,
5 Hbnl tSHbn + UnSx b" + VnSy7b" 
-DHb(Sxxbf+Syb")
(2.57)
S ~ k"- - Pb
1~~Sbn(~ Hb
SMbn±'t SMbn + UnSxb" + VnS,"bn 
-DMb(Sxxbn + Sybn)
= -k_ SMb" - (1 - SMbn) (2.58)
R contains no derivatives and is calculated explicitly according to equation (2.21).
In the computational domain, it is rewritten as,
R= kH[Hb] SHb _ _ SHb
(2.59)
+ k Mb[Mb] SMbn _ (1 _ SMbn)(M,
Table 2.3 lists all of the oxygen diffusion constants used in this model for the normal
blood and their values in comparison with those of the Le Floch-Harris model. Most
parameter values are nearly identical with the exception of the Hill coefficient and
the oxygen concentration at 50% hemoglobin and myoglobin saturation.
Table 2.3 - Oxygen Diffusion Parameters for normal blood
Tekleab-Harris model vs. Le Floch-Harris model
Value
Tekleab-Harris Model | LeFloch-Harris Model
_______________ i ____________ I ______________ I
02 diffusion constant
Diffusivity of
Hemoglobin
Diffusivity of
Myoglobin
Hb dissociation rate
constant
Mb dissociation rate
constant
Hb concentration in
RBC
Mb concentration in
tissue
02 concentration at
50% Hb saturation
02 concentration at
50% Hb saturation
02 consumption rate
in tissue
2.40 x 10-9
S
m 2
1.40 x 10~11 sS
6.10 x 10-11 s
S
44s-1
15.6s-1
mol
21.099-
m 3
mol
0.4
mol3.430 x 10-2
mol3.271 x 10-3 30
-6.1321
mol
X 10-3 M01
m 3-s
m
2
2.41 x 10-
1.38 x 10-11
6.10 x 10-11
S
2
s
44s~1
N/A
mol
21.099-
m3
mol
0. 4
4.412 x 10-2 3
mol7.981 x 10-3 3
-6.1321
mol
x 10~ 3  -01
m3 -s
Constant Symbol
D Hb
DMb
[Hb]
[Mb]
HbC5 0%
MbC50 %
M
Henry's law constant
Hill coefficient [ 19 ]
1.029
x 10-s mol
M3- Pa
2.7
1.130
x 10- mol
M3- Pa
2.2
To simulate the sickle blood, we modify four parameters. The diagram in Figure 2.8
shows the relative values of these four parameters between the normal and sickle
cases.
p- -
membranc stiffncss (.kRBc)
Hill coefficient (n)
pO2 at 50% lHb sat. ( )
Arterial P0 2 (pg **r*a)
Sickle
RBC
minbrane stiffncss (kRec')
Hill coefficient (n)
pO2 at 50% Hb sat. (p02oc,
Arterial pO2 (p0r)
Figure 2.8 - Healthy vs. Sickle RBC
Notice the increased membrane stiffness, increased P02 at 50% Hb
saturation, increased Hill coefficient, and decreased arterial P02 for the
sickle RBC.
The changes in these values in the sickle case cause a right-shift in the hemoglobin
oxygen saturation curve. Figure 1.9 shows the shifted hemoglobin saturation curve
for the sickle case.
Red Blood Cells
Healthy
RBC
-- --- .... ....
Normal and Sickle Hemoglobin Saturation Curves
0.9-
0.8-z
0.6-
'Z 0.5 -/
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0 .4 .. .............. .. .............. ... ......
0.3 /
0.1 /Normal Hemoglobin
Sickle Hemoglobin
0 9
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P 02 [kPa]
Figure 2.9 - Normal vs. Sickle Hemoglobin Saturation
The increased pQ5O% increased Hill coefficient, and decreased
arterial values cause a right-shift in the hemoglobin saturationP02
curve.
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3 Results
In this chapter, the data is presented for both the normal and sickle
microcirculation. The simulations were run by varying the sickle microcirculation
conditions, including the RBC membrane stiffness. The 24 test cases are explained
in detail below.
3.1 Test Cases
The microcirculation numerical code was designed to run two simple cases, the
normal microcirculation and the sickle microcirculation. The simulation for the
normal and sickle cases are identical with the exception of four critical parameters.
These four parameters and their values for both the normal and sickle blood
scenarios are listed in Table 3.1.
Table 3.1
Parameter
Microcirculation Simulation Parameters
| Normal Case Value | Sickle Case Value
____________ ____________ I ____________
Hill coefficient (n)
Po2 at 50% Hb
saturation (pH2
Po2 in arteries
2.7
3.33 x 103Pa
(25 mmHg)
1.27 x 104 Pa
(95 mmHg)
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3.0
5.33
(40
1.07
(80
x 103Pa
mmHg)
x 104Pa
mmHg)
rpgterial
stiffness index U) 0.0 0.0; 0.2; 0.5; 1.0; 2.0
The stiffness index is zero for the normal case, meaning that the stiffness of the RBC
membrane is a constant value everywhere, regardless of local oxygen concentration.
The sickle case, however, is simulated at a variety of stiffness indices ranging
between 0 and 2. At stiffness index values greater than 0, the RBC membrane
stiffness is related to the local oxygen concentration. The sickle case is tested at five
different stiffness indices, thereby creating six test cases in total - five sickle
microcirculation test cases and one normal microcirculation test case.
The microcirculation model approximates the RBC's initial shape as an ellipse,
which eventually reaches a steady shape. The geometry of the RBC membrane is
defined by the function #. The RBC is defined by the region # < 0. The function is
initialized as an ellipse, according to the equation,
#(x,y) = Ib2(x - O)2 - a 2 (y - yo) 2 - ab (3.1)
where (xo,yo) are the coordinates for the center of the ellipse, and a and b are the
semi-major and semi-minor axes. Before entering the capillary, the RBC at rest has
a biconcave disc shape, which is approximated as an ellipse. In the simulation, as
the RBC begins to move, it morphs into a biconcave shape. It would also be of
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interest, for comparison, if the simulation began with the asymptotic value for the
geometry as shown in Figure 3.1. The asymptotic shape may affect the speed at
which the RBC traverses the capillary as well as its ability to deliver oxygen to its
surroundings.
Steady State RBC GeometryElliptical RBC Geometry
0.5
01
-0.5
-1
- 0.5
0
- -0.5-0 -1 -0.5
Figure 3.1 - RBC initial geometries
Test cases #01-#06 and #13-#18 use the elliptical geometry to define the RBC
shape, while test cases #07-#12 and #19-#24 use the asymptotic RBC shape.
The asymptotic geometry was obtained by running the elliptical RBC until the
cell reached an asymptotic geometry.
Using two different initial geometries doubles the number of test cases, giving us 12
test cases.
The periodicity of our model allows the RBC to exit the frame of reference and enter
on the opposite boundary. Although the plasma and cell in the capillary are flowing,
the tissue does not, so the cell is flowing past same tissue segments repeatedly as its
...................   ..................... -  . .......
oxygen content diminishes. The periodic boundary conditions will be used to
analyze the oxygen consumption in a specific region of tissue, so for a portion of the
test cases, a short, fixed-length segment of capillary will be used.
Table 3.2 - Microcirculation Test Cases
Channel Length RBC initial Normal/Sickle Stiffness(l ) & Boundary .Test CaseC&ondn geometry (<p) Parameters index (j)Conditions
Normal 0.0 #01
0.0 #02
0.2 #03
e elliptical Sickle 0.5 #04
1.0 #05
2.0 #06
Normal 0.0 #07
0.0 #08
0.2 #09
asymptotic Sickle 0.5 #10
1.0 #11
2.0 #12
Normal 0.0 #13
0.0 #14
0.2 #15
elliptical Sickle 0.5 #16
1.0 #17
0 2.0 #18
Normal 0.0 #19
0.0 #20
0.2 #21
asymptotic Sickle 0.5 #22
1.0 #23
2.0 #24
It would also be interesting to see the behavior of the system as the cell flows
beyond new segments tissue. Therefore, I present a test case in which the length of
the channel the RBC flows through is increased. The new length must be long
enough that the simulation will end before the RBC reaches the end. For this long
capillary, a fixed boundary condition at the east boundary (arterial end of the
capillary) will be enforced. The oxygen concentration at this boundary will be set to
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the arterial oxygen concentration value. The west boundary will have a Neumann
boundary condition.
Varying each of these parameters gives us a total of 24 test cases. These test cases
are described in Table 3.2.
3.2 Simulation Results
Each test case was run for four seconds and data was collected at several intervals.
Pressure, u-velocity, v-velocity, oxygen concentration, and RBC geometry were
plotted.
3.2.1 Pressure
The pressure profiles for all test cases are nearly identical. The pressure variations
due to the membrane reaction forces on the flow are small enough that the pressure
gradient across the channel does not change. There is a large pressure gradient
created by the pumping of the heart. Only this imposed pressure gradient is visible.
Figure 3.2 shows the pressure profiles for the short and long capillaries.
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Figure 3.2 - Fluid Pressure Profile in Capillary
3.2.2 Velocity Profiles
The velocity profiles indicate a Poiseuille flow as expected in x-direction. Of the four
different test case parameters (normal/sickle parameters, stiffness index, initial
RBC geometry, channel length), the stiffness index has the largest impact on the U
and V velocity. The V velocity values are orders of magnitude smaller than the U
velocity. This is true for all test cases. The velocity profiles for both U and V are
presented below. Only the normal cases, and the sickle cases with the smallest and
...... . ................................... - - ------------- 
largest value for the stiffness index are presented in this section. A complete set of
the data can be found in Appendix A.
Figure 3.3 - U-Velocity, Test Case #01, #02, #06
Lx = 2, Elliptical Initial RBC Geometry
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Figure 3.4 - U-Velocity, Test Case #07, #08, #12
Lx = 2, Asymptotic Initial RBC Geometry
TC07 - Nominal case, j = 0.0
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Figure 3.5 - U-Velocity, Test Case #13, #14, #18
Lx = 10, Elliptical Initial RBC Geometry
TC13 - Normal case, j = 0.0
05 0.3
04 0.4 ~~- -- -
2.
03 0.3
02- 0.2
2
01 0.1
00-
-01 -j -0.1
-02 -0.2
-03 -0.3
05
-04 0.4
-0 50. 0
05 4 3 2 C 1 2 3 4 6 5 4 1 2 0 2 3 4 5
x
TC14 - Sickle case, j= 0.0
050.5 3
04 -0.4
25
03 0.3
02- 0.2
01 01
0 > 0 15
-01 -0
-022 -02
-03 -0.3
05
-0 4 0.4- --
-050.6
-O% -4 -3 -2 -1 C 2 3 4 5 -5 -4 -2 -2 1 0 1 2 3 4 5
TC18 - Sickle case, 2.0
05 05 3
04 - 0.4
25
03 03
02 0.2 2
01 01
0.05
-01 -01
-02 -0.2
-03 -0.3
04 0.4 
-0055 -4 -3 -2 -1 1 2 3 4 5
t=1
-5 -4 2 -2 0 1 2 3 4
t=4
Figure 3.6 - U-Velocity, Test Case #19, #20, #24
Lx = 10, Asymptotic Initial RBC Geometry
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Figure 3.7 - V-Velocity, Test Case #01, #02, #06
Lx = 2, Elliptical Initial RBC Geometry
TC01 - Normal case, j = 0.0
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Figure 3.8 - V-Velocity, Test Case #07, #08, #12
Lx = 2, Asymptotic Initial RBC Geometry
TC07 - Normal case, j = 0.0
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Figure 3.9 - V-Velocity, Test Case #13, #14, #18
Lx = 10, Elliptical Initial RBC Geometry
TC13 - Normal case, j = 0.0
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Figure 3.10 - V-Velocity, Test Case #19, #20, #24
Lx = 10, Asymptotic Initial RBC Geometry
TC19 - Normal case, j = 0.0
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3.2.3 RBC Geometry and 02 Concentration
The RBC Geometry and oxygen concentration profiles were superimposed onto one
figure. This overlay will help identify the impact of the geometry on the oxygen
concentration profile. Only the normal cases, and the sickle cases with the smallest
and largest value for the stiffness index are presented in this section. A complete set
of the data can be found in Appendix A.
Figure 3.11 - 02 Concentration, Test Case #01, #02, #06
Lx = 2, Elliptical Initial RBC Geometry
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Figure 3.12 - 02 Concentration, Test Case #07, #08, #12
Lx = 2, Asymptotic Initial RBC Geometry
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Figure 3.13 - 02 Concentration, Test Case #13, #14, #18
Lx = 10, Elliptical Initial RBC Geometry
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Figure 3.14 - 02 Concentration, Test Case #19, #20, #24
Lx = 10, Asymptotic Initial RBC Geometry
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4 Discussion of Results and Implications
This section discusses the numerical simulations results and any conclusions we can
draw from the data. Specifically, we investigate the RBC and its interaction with the
surrounding environment. The plasma velocity profiles and oxygen concentration
profiles are analyzed for both sickle and normal RBCs. This analysis helps us
characterize the most influential factors that determine the flow of RBCs and the
state of their surrounding environments.
4.1 Velocity Profiles
As stated previously, the velocity profiles indicate a quasi-steady Poiseuille flow.
Virtually zero difference is seen in the velocity profile between the normal case and
the sickle case with stiffness index j = 0. This similarity in the profiles can be
explained by these two test cases having the same stiffness, and thus the same
stress, across the RBC membranes. Because the membrane stress is directly
correlated to the fluid pressure drop across the membrane, we do not expect there
to be any difference between two test cases with identical stiffness indices.
Figure 4.1 and Figure 4.2 illustrate this point by comparing the normal test cases,
#01 and #07, with their sickle case counterparts, test cases #02 and #08, both at a
stiffness index values of zero (healthy RBC membrane stiffness). Although test cases
#03-#06 and #09-#12 are also sickle test cases, the stiffness indices is larger than
that of the test cases #02 and #08, ranging from j = 0.2 to j = 2.0. By comparing
these cases, we can assess the impact of the sickle parameters, independent of the
RBC membrane stiffness. It is important to note that there is no perceivable
difference between these plots, which indicates that the flow velocity perturbations
are due purely to the stiffness index, and not an effect of the altered Hill coefficient,
Hb arterial
P 0 2 ,50% or p0 . It is important to note that other factors not tested in these
simulations may also cause perturbations to the mean flow, for example RBC size or
variability in capillary diameter. These variations may be tested with this model in
the future.
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Figure 4.1 - U for Normal and Sickle cases
Figure 4.2 - V for Normal and Sickle cases
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Differences are observed, however, between sickle test cases at different stiffness
indices. As expected, higher stiffness indices produce larger perturbations in the
Poiseuille flow because the less compliant sections of the cell membrane create
greater resistances to the flow. The resistance to the flow is manifested as a
pressure drop across the cell membrane. This is most readily apparent in a
comparison between test cases #02 and #06, and also between test cases #08 and
#12.
In Figure 4.3, it is apparent that the perturbations in the Poiseuille flow are caused
by the RBC membrane stresses. Test cases #02 and #08 show nearly straight,
horizontal U-velocity contour lines, with slight perturbations around the edges of
the RBC membrane. Test cases #06 and #12, however, show very large changes in
the velocity contours from a normal Poiseuille flow. This is also apparent in Figure
4.4 for the V-velocity profiles. In a true Poiseuille flow, the profile for the V-velocity
component would be zero everywhere. While the V-velocity values are extremely
small, we see some perturbations near the tail and nose of the RBC. The pressure
jump across the membrane is greatest at these points due to the large curvature of
the membrane at these points. These perturbations create small, weak vortices in
the flow, causing small eddies at the tail ends of the RBC as seen in Figure 4.4. The
V-velocity values are an order of magnitude larger in test cases #06 and #12
(greatest stiffness index) than they are in #02 and #08 (smallest stiffness index) due
to the increase in the RBC membrane stiffness.
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Table 4.1 - Perturbation in Velocity Profile
PerturbationNormal/Sickle Stiffness ielocityTest Cases Paaees idx() in VelocityParameters index (j) Profile
#01, #07, #13, #19 Normal 0.0
#02, #08, #14, #20 0.0
#03, #09, #15, #21 0.2 +
#04, #10, #16, #22 Sickle 0.5 ++
#05, #11, #17, #23 1.0 +++
#06, #12, #18, #24 2.0
Table 4.1 shows the relative level of perturbation of the velocity profile with respect
to the normal RBC case. From the U and V-velocity profiles we can determine the
level of perturbation from the mean flow. The normal case has some level of
perturbation; however it is much smaller than the sickle cases with higher levels of
membrane stiffness.
From these observations we can conclude that the stiffness index has an impact on
the profile. High stiffness regions of the membrane can cause perturbations in the
flow. However, we do not see a perturbation to the mean flow large enough to
retard the motion of the RBC. In all cases, the RBC reaches approximately the same
position at any time point in the simulation. Perhaps for longer duration
simulations, we may notice a small difference, although it most likely would not be a
significant change.
4.2 02 Concentration Profiles
The oxygen concentration profile is constant throughout the system initially, at t=0.
Over the next 1600 iterations through t=4, the oxygen dissipates from the system as
it is consumed by the tissue. The flow of oxygen from the RBC, through the plasma
and into the tissue is represented by contour lines in the plots of Figure 4.5. These
plots show the system early in the simulation at t=1 and at later time t=4. Notice the
highest concentration of oxygen is inside the RBC. These profiles only consider free
oxygen, and not hemoglobin bound oxygen.
The oxygen profiles for all sickle RBC cases, regardless of the stiffness index, are
almost identical. There are slight differences very close to the sickle RBC due to the
difference in shape of the membrane; however, far away from the sickle RBC, in the
tissue, we find that the profiles are very similar. The normal RBC case however,
shows a very different oxygen profile from the sickle RBC case. The oxygen
concentration throughout the system is significantly higher in the normal case
except very close to the cell center. This indicates that the impact of the sickle
parameters (increased Hill coefficient, increased p'oso, and decreased paterial) is
much greater than that of the membrane stiffness.
This is consistent with our understanding of the dynamics of the cell and oxygen
transport. Although the increased stiffness of the cell causes membrane rigidity and
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changes the flow velocity near the cell, these changes are very small in the oxygen
transport equations. The oxygen transport equation has a diffusion term, a
advection term, and a generation/consumption terms for the different regions of the
plasma. The changes in the velocity profile caused by the increased stiffness are
only found inside the plasma. However, the slight perturbations that we observe are
small enough that the diffusion, and generation/consumption terms dominate the
oxygen concentration profile in the system. In larger vessels with higher speed
flows and greater levels of turbulence, this may not be the case.
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Figure 4.6 - Normal and Sickle 02 concentration for long, fixed left B.C. capillary
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As seen in Figure 4.5, the oxygen concentration profile of the normal RBC case
indicates higher oxygen concentration values at all points in the tissue and most of
the plasma with respect to the sickle RBC case. Near the cell, however, the sickle
RBC case shows higher values of oxygen as time elapses. This seems counter
intuitive due to the lower initial (arterial) pressure in the RBC. In fact, at earlier
times, we notice the normal case has higher oxygen concentration values
everywhere with respect to the sickle RBC case. These increased levels of free
oxygen inside the sickle RBC occur because the hemoglobin saturation levels drop
more quickly than in the normal RBC. This happens because the increased Hill
coefficient and increased Pos cause a right-shift in the hemoglobin saturation
curve. The relationship between the two curves can be seen in Figure 4.7.
Although there is a lower amount of total oxygen content in the sickle RBC case,
both bound and unbound, the low saturation of the sickle RBCs yields more free
oxygen around the cell. This occurs because the sickle hemoglobin proteins are
much weaker at binding oxygen molecules, so they lose whatever oxygen they may
have rather quickly. After releasing the oxygen molecules, the sickle oxyhemoglobin
change conformation, becoming sickle deoxyhemoglobin. The sickle
deoxyhemoglobin bind to one another, creating long branches in the RBC, and thus
have a much lower probability of rebinding other oxygen molecules in their
surroundings. Therefore, we expect to see more free oxygen around the cell, but not
throughout the system.
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Figure 4.7 - Normal and Sickle Hemoglobin Saturation Curves
The sickle Hemoglobin curves shifts right due to a
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Figure 4.6 shows the simulation for a longer, non-periodic capillary with one cell
flowing down the channel. In this case, the left boundary is fixed at the arterial
pressure value, which represents the arterial end of the capillary. The initial
condition is a linear oxygen concentration gradient across the capillary. As the
simulation runs, the oxygen is consumed by the tissue and advected by the plasma
flow. Although the profile looks different from the short, periodic capillary, the
results are consistent. The oxygen concentration throughout the system is much
higher in the normal case except very near to the center of the RBC.
. . .................... . ...... . .... . .....
4.3 Comparisons with Previous Models
It is important to compare our model to previous models. The Le Floch-Harris
model [ 8 ] and Secomb's model [ 4] are used for comparison. Although this model
simulates capillary blood flow, there are several differences between this model and
the two models to which it is being compared. These differences must be taken into
consideration when comparing the results. First, the major difference in this model
is that we only look at an individual erythrocyte traveling down the axis, and its
impact on the oxygen profile, whereas the Le Floch-Harris and Secomb models
account for multiple cells, periodically spaced along the length of the capillary. The
spatial period is based on the hematocrit level.
4 VRBC
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Despite these differences, in both cases we should see a drop in P0 2 along the length
of the capillary as well as radially outward from the centerline of the capillary, into
the tissue. First, let's examine the Le Floch-Harris model. In Figure 4.8, Le Floch
demonstrates the experimental results from case (4a), which is most similar to this
model.
- t=4.1920me (Iteration 28800)
i4al distaneIn metrs
Figure 4.8 - Le Floch's results
02 contours show the P0 2 in the RBC, capillary, and tissue.
The oxygen partial pressure contour lines indicate a significant drop in Po2
downstream, both in the capillary as well as in the tissue, and a slight radial drop in
the oxygen levels.
Secomb's model shows similar behavior as seen in Figure 4.9.
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Figure 4.9 - Secomb's results
A: Drop in average P0 2 along the length of the capillary.
B: P0 2 at radial sections of the capillary. Z indicates position along
length of capillary
The differences in the models are readily apparent when comparing the oxygen
contour lines from our model. For comparison, we will use test case #19. Figure
4.10, shows the oxygen concentration and RBC geometry.
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Figure 4.10 - Test Case #19 Oxygen Concentration
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By looking at Figure 4.8, Figure 4.9, and Figure 4.10, we can identify major
differences in the oxygen concentration profiles in the capillary and tissue. Let us
first consider the profile in the axial direction. In Secomb's figure, this data would
be represented by plot A. All three figures show an axial decrease in oxygen
concentration (directly proportional to oxygen partial pressure). Le Floch's data
shows a nearly constant, linear drop in oxygen concentration axially, both in the
tissue and in the capillary. Further away from the capillary, the values are slightly
lower, but the axial trend is consistent. Secomb's data, along with the data from this
model, indicates a non-linear decrease in oxygen concentration. In fact, they both
report a higher drop in oxygen concentration towards the entrance of the capillary.
As the RBC moves further down the capillary, the oxygen concentration begins to
slowly level off. Therefore in the axial direction, our data is more consistent with
that of Secomb than Le Floch. However, the concentration drop in our data is much
more significant than that of both Secomb and Le Floch. This is primarily due to the
fact that our model can only account for one RBC in the capillary. This is a major
difference in these models. In order to make a more fair comparison between the
models in the future, it must be updated to account for multiple RBCs in the
capillary at once.
Next let us consider the profiles in the radial direction. In Secomb's figure, this data
would be represented by plot B. In the radial direction, there are major difference
between our data and that of Le Floch and Secomb. Secomb's and Le Floch's data
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both show a logarithmic drop from the capillary wall into the tissue. The radial
concentration drops are consistent along the axis of the capillary, but the values are
lower as you move downstream. In the data from this model, there is also a radial
drop from the capillary into the tissue, however, the oxygen concentration levels are
much lower with more significant drops further away from the entrance of the
capillary. The region closest to the capillary entrance is least affected because a
fixed oxygen concentration boundary condition is used on the left boundary. This
significant drop is in large part due to the fact that our model has only one RBC.
This idea is supported by the fact that we can see small increases in the regions
closest to the RBC. Notice that in Figure 4.10, at x = 0, the oxygen concentration
values are slightly higher than a little further upstream at x = -1. Further into the
tissue, this is less apparent because it takes some time for the oxygen to diffuse into
that region.
It appears that most of the differences between this model and Le Floch's and
Secomb's models arise from the fact that the tissue everywhere is consuming
oxygen, while only the tissue near the single red blood cell is receiving oxygen.
Notice the higher regions of oxygen near the entrance of the capillary have contour
lines that are more vertical like that of Le Floch. Because only one cell is used, less
oxygen is being diffused throughout the system. Also, the middle regions of the
tissue (-2 < x < 2), has lower oxygen levels than the region near the entrance of
the capillary at the right boundary as seen in Figure 4.10. Using a multi-cell model
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may produce results that are even more consistent with that of Secomb and Le
Floch.
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5 Conclusion
This model was designed to serve as a fast and efficient method for calculating
capillary flow conditions and local oxygen concentration for both healthy and sickle
RBCs. The model utilizes computational domain representative of a capillary
surrounded by muscle tissue. Given specific initial and boundary conditions, the
model produced overall results consistent with the basic understanding of flow
conditions and oxygen concentration profiles in human capillaries. Perturbation
analysis allows us to determine differences in flow conditions and oxygen profiles
from the mean flow. For the purpose of this perturbation analysis, the mean was
determined to be ideal flow conditions and oxygen concentration levels found in
healthy RBCs systems.
5.1 Findings
Comparing the simulation results between the various test cases have led to several
conclusions. First, the perturbations in the flow velocity are due primarily to an
increase in cell membrane stiffness. A variety of RBC membrane stiffness values
were simulated in different test cases. Regardless of initial and boundary conditions
used, the flow velocities showed similar trends between the test cases. It was clear
that perturbations to the mean Poiseuille flow were more apparent as the stiffness
of the membrane was increased.
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The perturbations in the oxygen concentration are largely a function of the three
sickle parameters, the Hill coefficient (n), poo and p arterial. The cell membrane
stiffness does however, play a small role in the oxygen concentration very close to
the RBC. Of the 24 test cases, the first half were simulated with periodic boundary
conditions using a smaller computational grid while the second half were simulated
with a fixed boundary on the left end and a Neumann boundary condition on the
right end. In both sets of test cases, the sickle parameters played the largest role in
the oxygen concentration. In the sickle RBC case, the system as a whole has
noticeably lower oxygen content than the healthy RBC case. The concentration
values are lower in the tissue and the plasma region far from the RBC. This,
however, is not the case very close to the RBC. In the plasma region very close to
the RBC, and inside the RBC, we observe higher oxygen concentration levels than
the healthy case, due to the sickle RBC's poor ability to carry oxygen. The sickle RBC
cannot saturate its hemoglobin as much as a healthy RBC due to the right-shift in the
saturation curve as illustrated in Figure 4.7.
The oxygen concentration follows general trends as seen in Le Floch's and Secomb's
work. As we move downstream in the system, the oxygen content of the RBC, the
plasma, and the surrounding tissue diminish. Additionally, at any axial cross section
in the capillary, the highest level of oxygen can be found at the center and it
diminishes radially such that the tissue furthest away has the lowest concentration.
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5.2 Recommendations
To gain a better understanding of the dynamics of sickle cell using this model,
several test cases can be developed. In these simulations, the flow parameters were
unchanged, such as the density and viscosity of plasma. It may be of interest to test
whether small changes in these values in both the sickle and healthy cases may
impact the perturbations in the flow or the oxygen concentrations. It may also be
interesting to simulate moderate exercise, in which there may be slightly faster
speed flows and larger oxygen consumption rates in the tissue.
Several modifications can be made to improve this microcirculation model. The first
suggested modification would be to change the model to allow multiple cells. We
would then be able to more accurately replicate the oxygen delivery system in real
human capillaries. We would be able to vary the hematocrit level for sickle and
healthy cases, as well as any other stressing cases we may like to consider.
The capillary in this system is model as a two-dimensional fluid flow between two
flat plates, using a Cartesian coordinate system. Although it may be more
computationally intensive, in the future we might consider creating a model that
uses a three-dimensional axisymmetric flow, using a cylindrical coordinate system.
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Capillaries in the human body do not have constant diameters. In reality, they have
converging and diverging cross sections. Allowing variable capillary radius
(diverging or converging capillaries) would make the model more authentic.
In a real sickle RBC, the membrane stiffness is not fixed throughout its life, or even
the duration it traverses a capillary. In fact, it is indirectly related to the hemoglobin
saturation levels. As the RBC releases oxygen, the membrane becomes more rigid.
By creating a time-dependent, or oxygen saturation dependent membrane stiffness
model, we would be able to capture the dynamic nature of the membrane stiffness.
With these changes to the model, it would be good to see how the data compares to
that of other models, such as Le Floch's or Secom's model. These changes would
allow more direct comparisons to be made. It would also be very insightful to
compare our data to experimental data conducted either in microfluidic devices or
in biological samples.
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Appendix A - Full Data Set
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Figure A.1 - U-Velocity, Test Case #01 - #03
Lx = 2, Elliptical Initial RBC Geometry
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Figure A.2 - U-Velocity, Test Case #04 - #06
Lx = 2, Elliptical Initial RBC Geometry
TC04 - Sickle case, j = 0.5
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Figure A.3 - U-Velocity, Test Case #07 - #09
Lx = 2, Steady State Initial RBC Geometry
TC07 - Nominal case, j = 0.0
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Figure A.4 - U-Velocity, Test Case #09 - #12
Lx = 2, Steady State Initial RBC Geometry
TC10 - Sickle case, j =0.5
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Figure A.5 - U-Velocity, Test Case #13 - #15
Lx = 10, Elliptical Initial RBC Geometry
TC13 - Normal case, j = 0.0
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Figure A.6 - U-Velocity, Test Case #16 - #18
Lx = 10, Elliptical Initial RBC Geometry
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Figure A.7 - U-Velocity, Test Case #19 - #21
Lx = 10, Steady State Initial RBC Geometry
TC19 - Normal case, j = 0.0
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Figure A.8 - U-Velocity, Test Case #22 - #24
Lx = 10, Steady State Initial RBC Geometry
TC22 - Sickle case, j = 0.5
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Figure A.9 - V-Velocity, Test Case #01 - #03
Lx = 2, Elliptical Initial RBC Geometry
TC01 - Normal case, j = 0.0
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Figure A.10 - V-Velocity, Test Case #03 - #06
Lx = 2, Elliptical Initial RBC Geometry
TC04 - Sickle case, j = 0.5
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Figure A.11 - V-Velocity, Test Case #07 - #09
Lx = 2, Steady State Initial RBC Geometry
TC07 - Normal case, j = 0.0
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Figure A.12 - V-Velocity, Test Case #10 - #12
Lx = 2, Steady State Initial RBC Geometry
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Figure A.13 - V-Velocity, Test Case #13 - #15
Lx = 10, Elliptical Initial RBC Geometry
TC13 - Normal case, j = 0.0
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Figure A.14 - V-Velocity, Test Case #16 - #18
Lx = 10, Elliptical Initial RBC Geometry
TC16 - Sickle case, j = 0.5
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Figure A.15 - V-Velocity, Test Case #19 - #21
Lx = 10, Steady State Initial RBC Geometry
TC19 - Normal case, j = 0.0
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Figure A.16 - V-Velocity, Test Case #22 - #24
Lx = 10, Steady State Initial RBC Geometry
TC22 - Sickle case, j = 0.5
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Figure A.17 - 02 Concentration, Test Case #01 - #03
Lx = 2, Elliptical Initial RBC Geometry
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Figure A.18 - 02 Concentration, Test Case #04 - #06
Lx = 2, Elliptical Initial RBC Geometry
TC04
Sickle case, j = 0.5
TC05
Sickle case, j = 1.0
TC06
Sickle case, j = 2.0
2-
1.5
05
-0
-0.5
-1
-15 -
-2
-1 -05 0 0.5
x
-1 -5 0 0.5
2
15
05
-0
-05
-- 1
-1.5
-2-
-1 -05 0 05
t x
2 I
-0.5 - -- 01-5
1.57
I 1  1 -
1.25 1.75 1.25-
1t 25F- --- 1.25 -t2
05 .5 -
1.-5.755
22.i
172 
--- 15 1.8
.5 -12'5- -125- 42A
-1 :: 
-
1.- 75 1.75
-1 5
-2-
- -0.5 0 05 1
x
1.5 .-0 5
15
1 __4- _ 1
125 1-425- 125
C.5 -1 5 15
-0 .57 1 7
-1 s ~~ ~_ ~.5 - .8
2
1-5 0.5 0 .1
1 5
1 -. 0 05
- 0. - 4 5 .
15 - 5 ~
L7
-0 215 12- -
-1. 1.
22
2 1.7
-1 -0.5 0 0.5
t=2
2
1 5
05
0
-05
-1
-15
-2
5 -- 75---07s----- -e 7i
-125 725 .2
1.5. 
-
-45
5 -- 07
06
55
5 - 75--- I6----
-2-
-1 -0.5 0 0.5
t=4
125
--- 
--.7 0.73 - -0.76
5
1.5
1 - 1,25 2S
-- 0 75-9 75--0.
-0.5 0 0.5
4
2
1 5 - - 7 - -- 0. 6
-
3
- i25- t  2
05 2
S5 5 .5
-05 i'15 
_ t
15 1.25- - 2
-15 75- 9 75-------
-2
0
-1 0.5 0 0.5 1
Figure A.19 - 02 Concentration, Test Case #07 - #09
Lx = 2, Steady State Initial RBC Geometry
TC07
Normal case, j = 0.0
TC08
Sickle case, j = 0.0
TC09
Sickle case, j = 0.2
2-
1.5
0.5 $17---.76-~~~$ 75
>- 0
-0.5 y3---.76---- 5
-1 5
-2
-1 -05 0 0.5
1.5-
05
-0.5-
-1 5 -
-2 -
-1 -05 0 0.5
x
2-
05
-05
-15
-2-
-1 -05 0 05
t =
~0- -- -- 1----0 i
4.26------25-^ -4.26
1 5 '1. -- 16
75
1.75 ~ 1, .55
t75
1.75
-1. 25- 1.5
---- 1~~
- ,S (
-1 -0.5 0 0.5
2-
03~-0 5-~4
05-72
175
0-
.5
-0.5 1
-1 5 -i - -- 7
-1 5
-2
-1 -0.5 0 05
21
1 5
07 07S 0 75
10
175 6
-1 0
1.-- - - 1 5 - - - -- 5
-1.5
-2
-1 -05 0 0.5
t 2
2
15
1
05
10
-0S
-15
-2
2
15
05
0
-05
-15
-2
4
2
15
3
1
05 25 2$- 25 2
>~0 2
.5
-0 5 75 -
-1 -
-15 -- g - 0.75 0 .
-2
-1 -05 0 0.5 1
t=4
126
125 1-25 -25
1.5
.25 - - 1.25
-0 1 1
-0.5 0 0.5 1
------- '7 ------ 0.-
25s -25 -- 521
- 1
-0 5 0 0 5
x
Figure A.20 - 02 Concentration, Test Case #10 - #12
Lx = 2, Steady State Initial RBC Geometry
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Figure A.21 - 02 Concentration, Test Case #13 - #15
Lx = 10, Elliptical Initial RBC Geometry
TC13 - Normal case, j = 0.0
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Figure A.22 - 02 Concentration, Test Case #16 - #18
Lx = 10, Elliptical Initial RBC Geometry
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Figure A.23 - 02 Concentration, Test Case #19 - #21
Lx = 10, Steady State Initial RBC Geometry
TC19 - Normal case, j = 0.0
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Figure A.24 - 02 Concentration, Test Case #22 - #24
Lx = 10, Steady State Initial RBC Geometry
TC22 - Sickle case, j = 0.5
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Appendix B - Code
function microcirculation(lx,ss, periodic_flag)
%NAVIERSTOKES -- > MICROCIRCULATION
% Solves the incompressible Navier-Stokes equations in a rectangular
%6 domain with prescribed velocities along the boundary. The solution
% method is finite differencing on a staggered grid with implicit
% diffusion and a Chorin projection method for the pressure.
% Visualization is done by a colormap-isoline plot for pressure and
% normalized quiver and streamline plot for the velocity field.
% The standard setup solves a lid driven cavity problem.
% 07/2007 by Benjamin Seibold, http://www-math.mit.edu/-seibold/
% Feel free to modify for teaching and learning.
% 04/2010 Modified by Yonatan Tekleab (ytekleab)
%0 This code has been modified to simulate the flow of a red blood cell
% (RBC) within a capillary.
%6 -level-set method implemented to create RBC boundary
% -jump matrix to incorporate jump in fluid pressure due to membrane
%- stresses
% -boundary conditions changed to periodic flow on the E & W
%- boundaries and no-flux/no-slip along N & S boundaries
% -axial pressure gradient applied
% -oxygen diffusion incorporated
% Last modified: ytekleab Jan 23, 2011 16:25:00
%------------------------------------------------------------------------
close all; clc;
if nargin < 3
periodic_flag = 0;
end
if nargin < 2
ss = 0;
end
if nargin < 1
lx = 10;
end
% DEFINE MICROCIRCULATION PARAMETERS
% reference values
pHb50_0 = 3.333e3; % reference pHb50 [Pa]
pO2aO = 1.2666e4; % reference pO2a [Pa]
% sickle/normal RBC, 02 parameters
sickle = -logical(input('Sickle RBC [0] or Normal RBC [1--default] case? '));
if -sickle,
fprintf(['\n***NORMAL RBC CASE***\nEntering stiffness index of "'',...
' will give normal RBC Membrane stiffness\n']);
n = 2.7; % Hill coefficient for normal blood
pHb50 = pHb50_0; % p02 at 50% Hb saturation [Pa] for normal blood
pO2a = pO2a_0; % Arterial p02 [Pa] for normal blood
else
fprintf(['\n***SICKLE RBC CASE***\nEntering stiffness index of "0"',...
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' will give normal RBC Membrane stiffness\n']);
n = 3.0; % Hill coefficient for sickle blood
pHb50 = 5.333e3; % p02 at 50% Hb saturation [Pa] for sickle blood
p02a = 1.0666e4; % Arterial p02 [Pa] for sickle blood
end
index = 0; % Stiffness index (0 for normal RBC)
in = input('\nEnter the stiffness index (between 0 and 2): ');
if in > 2 || in < 0,
fprintf(['\nBad index! Must be [0 2]\nWill proceed using index value of
',num2str(index)]);
else
index = in; clear in;
end
% fluid, capillary & RBC parameters
rho = 1025;
Vavg = le-3;
Dcap = 9e-6;
mu = 1.4e-3;
Re = rho*Vavg*Dcap/mu;
Rk = 20.10e-6;
tissue [m]
V rbc = 9e-17;
a = 0.45;
direction)
b = Vrbc/((4/3)*pi*(a^2)*Dcap^3);
direction)
k mem = 1.9e-5;
dpdx = -(3.4e5)*(Dcap/(rho*Vavg^2));
dimensionalized)
% plasma density [kg/m^3]
% mean plasma velocity [m/s]
% capillary diameter [m]
% plasma viscosity [Pa-s]
% reynolds number
% capillary centerline to end of
% RBC volume [m^3]
% semi-major axis (vertical
% semi-minor axis (horizontal
% membrane stiffness [N/m]
% pressure gradient [Pa/m] (Non
% oxygen concentration parameters
Dox = 2.40e-9; % 02 diffusivity in plasma/tissue [m^2/s]
DHb = 1.40e-11; % diffusivity of oxyhemoglobin [m^2/s]
DMb = 6.10e-11; % diffusivity of oxymyoglobin [m^2/s]
alpha = 1.029e-5; % Henry's law constant [mol/(mA3-Pa)]
pMb50 = 3.179e2; % p02 at 50% Mb saturation [Pa] (Schenkman et.
al.)
cHb50 = pHb50*alpha;
cMb50 = pMb50*alpha;
cHb const = 21.099;
cMb const = 0.4;
kinvHb = 44;
kinvMb = 15.6;
M = -6.1321e-3;
cO2a = pO2a*alpha;
cHb50_0 = pHb50_0*alpha;
cO2aO = pO2aO*alpha;
% 02 concentration at 50% Hb saturation [mol/m^3]
% 02 concentration at 50% Mb saturation [mol/m^3]
% Hb concentration in RBC [mol/m^3]
% Mb concentration in Tissue [mol/m^3]
* Hb inverse rate constant [sec^-l]
% Mb inverse rate constant [sec^-1]
* tissue 02 consumption rate [mol/(m^3-s)]
% arterial c02 [mol/m^3]
% reference cHb50 [mol/m^3]
% reference cO2a [mol/m^3]
pO2v = 5.333e3;
cO2v = pO2v*alpha;
% -------- --T-
% DISCRITIZATION
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dt = le-2; % time step
tf = 0.4e+1; % final time
ly = 1; % height of capillary
nx = lx*50; % number of x-gridpoints
ny = ly*50; % number of y-gridpoints
nsteps = tf; % number of steps with graphic output
nyc = round(ny* (2*Rk/Dcap)/2)*2;
lyc = nyc/ny;
x = linspace(-lx/2,lx/2,nx+l); hx = lx/nx;
y = linspace(-ly/2,ly/2,ny+1); hy = ly/ny;
yc = linspace(-lyc/2,lyc/2,nyc+l);
[X,Y] = meshgrid(y,x) ;
ax = [min(x) max(x) min(y) max(y)]; axc = [min(x) max(x) min(yc) max(yc)];
k cfl = 1; Umax = 4;
if tf/ceil(tf/(kcfl*min(hx,hy)/(2*Umax)))<dt;
dt = kcfl*min(hx,hy)/(2*Umax);
end
nt = ceil(tf/dt); dt = tf/nt;
% fine grid discritization (f times finer than coarse grid)
f = 2; dtf = dt/f;
xf = linspace(min(x),max(x),f*nx+l); hxf = lx/(f*nx);
yf = linspace(min(y),max(y),f*ny+1); hyf = ly/(f*ny);
[Xf,Yf] = meshgrid(yf,xf);
% INITIALIZE RBC BOUNDARY - using level-set method
num shifto = 0; num shifti = 0;
nr = 3; % number of
reinitialization steps
x0 = -(lx/2)+b; y0 = 0; % ellipse center
phi = sqrt((b^2)*((X-y0).^2)+(a^2)*(Y-x0).A2)-a*b; % eqn of ellipse
if ss -= 0,
if lx == 2,
load('lx2_phiss.mat');
elseif lx == 10,
load('lx10_phi_ss.mat');
else
sprintf(['Steady State geometry only saved for lx=2 and lx=10\n'...
'Using elliptical geometry']);
end
end
phif = interp2(X,Y,phi,Xf,Yf); volf_0 = length(find(phif<0));
%---------------------------------------------------------------------------
% INITIAL/BOUNDARY CONDITIONS
% initial conditions
if periodicflag -= 0,
C = (cO2a/cHb50_0)*ones(nx,nyc);
else
C = linspace(c2a/cHb50_0,cO2v/cHb50_0,nx)'*ones(l,nyc);
end
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SHb = HbSat(pO2a,pHb5O,n)*ones(nx,nyc);
SMb = 0.57*ones(nxnyc);
U = ones(nx-l,ny); V = zeros(nx,ny-1);
Pmax = abs(dpdx*lx/2); Pmin = -abs(dpdx*1x/2);
Pgrad = linspace(Pmax,Pmin,nx)'*ones(1,ny);
cMb = cMbconst*ones(nx,nyc);cMb(:, (nyc-ny)/2+1:(nyc-ny)/2+ny) = 0;
M = M*ones(nx,nyc)*(Dcap/(cHb5O0*Vavg));M(:, (nyc-ny)/2+1:(nyc-ny)/2+ny) = 0;
% boundary flow conditions
uN = x*0+0; vN = avg(x)*0;
uS = x*0+0; vS = avg(x)*O;
uW = avg(y)*0+1; vW = y*0+0;
uE = avg(y)*0+1; VE = y*0+0;
% ----- -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
% INITIALIZE OPERATORS
fprintf('initialization')
% Pressure
Lp = kron(speye(ny),K1(nx,hx,lO))+kron(Kl(ny,hy,l),speye(nx));
perp = symamd(Lp); Rp = chol(Lp(perp,perp)); Rpt = Rp';
% U-Velocity
A = (1/Re)*(kron(speye(ny),K1(nx-l,hx,2))+kron(Kl(ny,hy,3),speye(nx-1)));
Lu speye((nx-l)*ny)+dt*A;
peru = symamd(Lu); Ru = chol(Lu(peru,peru)); Rut = Ru';
% V-Velocity
A = (1/Re)*(kron(speye(ny-1),Kl(nx,hx,3))+kron(Kl(ny-l,hy,2),speye(nx)));
Lv = speye(nx*(ny-1))+dt*A;
perv = symamd(Lv); Rv = chol(Lv(perv,perv)); Rvt = Rv';
% 02 Concentration
A =
(Dox/(Vavg*Dcap))* (kron(speye(nyc),Kl(nx,hx,1))+kron(K1(nyc,hy,l),speye(nx)))
Lc = speye((nx)*nyc)+dt*A;
perc = symamd(Lc); Rc = chol(Lc(perc,perc)); Rct = Rc';
% Hemoglobin Saturation
A =
(DHb/ (Vavg*Dcap) ) * (kron(speye (nyc) ,K1 (nx,hx, 1)) +kron(Kl (nyc,hy, 1) , speye (nx)))
Lshb = speye((nx)*nyc)+dt*A;
pershb = symamd(Lshb); Rshb = chol(Lshb(pershb,pershb)); Rshbt = Rshb';
% Myoglobin Saturation
A =
(DMb/(Vavg*Dcap))*(kron(speye(nyc),Kl(nx,hx,l))+kron(Kl(nyc,hy,l),speye(nx)))
Lsmb speye((nx)*nyc)+dt*A;
persmb = symamd(Lsmb); Rsmb = chol(Lsmb(persmb,persmb)); Rsmbt = Rsmb';
% ITERATE TO CALCULATE MICROCIRCULATION VALUES (phi,U,V,P,C)
fprintf(', time loop\n--20%%--40%%--60%%--80%%-100%%\n')
for k = 1:nt
% CALCULATE RBC GEOMETRY USING LEVEL-SET EQUATION
% boundary velocities
Ubc = dt/Re*([2*uS(2:end-l)' zeros(nx-l,ny-2) 2*uN(2:end-
1)']/hx^2+[uW;zeros(nx-3,ny);uE]/hy^2);
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Vbc = dt/Re*([vS' zeros(nx,ny-3) vN']/hx^2+[2*vW(2:end-1);zeros(nx-2,ny-
1);2*vE(2:end-1)]/hy^2);
% velocities(Ua,Va) and derivatives(Ud,Vd) at grid points
Ue = [uW;U;uE]; Ue = [2*uS'-Ue(:,l) Ue 2*uN'-Ue(:,end)]; %#ok<AGROW>
Ve = [vS' V vN']; Ve = [2*vW-Ve(l,:);Ve;2*vE-Ve(end,:)]; %#ok<AGROW>
Ua = avg(Ue')'; Ud = diff(Ue,1,2)/2;
Va = avg(Ve); Vd = diff(Ve,1,1)/2;
% transfer to fine grid
phif = interp2(X,Y,phi,Xf,Yf);
Uaf = interp2(X,Y,Ua,Xf,Yf); Vaf = interp2(X,Y,Va,Xf,Yf);
for i = 1:f,
phixf = (phif([2:end 1],:)-phif([end 1:end-1],:))/(2*hxf);
phiyf = (phif(:,3:end)-phif(:,l:end-2))/(2*hyf); phiyf = phiyf(:, [1
1:end end]);
F = (Uaf.*phixf+Vaf.*phiyf)./sqrt(phixf.^2+phiyf.A2+eps);
F = (F([end 1:end-l],:)+F([2:end l],:)+F(:,[l 1:end-1])+F(:,[2:end
end]))/4;
% level-set update & reinitialization steps
phif = phif-dtf*FabsgradP(phif,0.5*(hxf+hyf),F);
for ir = 1:nr
phif = phif-
dtf*FabsgradP(phif,0.5*(hxf+hyf),phif./sqrt(phif.^2+(hxf+hyf)^2),l);
end
if periodicflag -= 0,
% periodicity
phif (1,:) = phif (end,:);
end
% adjust for RBC volume loss/gain
volff = length(find(phif<O));
while(l-volff/volf_0)<-10*hxf*hyf
phif = phif + hxf*hyf;
volff = length(find(phif<o));
num shift1 = num shiftl-l;
end
while(l-volff/volf_0)>10*hxf*hyf
phif = phif - hxf*hyf;
phif = phif + hx*hy*[ones(nx*f+1,1)
ones (nx*f+1,1)];
volff = length(find(phif<o));
num shiftO = num shift0+1;
end
zeros(nx*f+l,ny*f-1)
end
% transfer to back to coarse grid
phi = interp2(Xf,Yf,phif,X,Y);
% CALCULATE VELOCITIES AND PRESSURE USING NAVIER-STOKES EQUATION
% treat nonlinear terms
gamma = min(l.2*dt*max(max(max(abs(U)))/hx,max(max(abs(V)))/hy),l);
UVx = diff(Ua.*Va-gamma*abs(Ua).*Vd,1,1)/hx;
UVy = diff((Ua.*Va-gamma*Ud.*abs(Va)),1,2)/hy;
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% calculate velocities(Ua,Va) and derivatives(Ud,Vd) at cell center
Ua = avg(Ue(:,2:end-1)); Ud = diff(Ue(:,2:end-1),1,1)/2;
Va = avg(Ve(2:end-l,:)')'; Vd = diff(Ve(2:end-l,:),1,2)/2;
U2x = diff(Ua.^2-gamma*abs(Ua).*Ud,1,1)/hx;
V2y = diff((Va.^2-gamma*abs(Va).*Vd),1,2)/hy;
U = U-dt*(UVy(2:end-l,:)+U2x+dpdx*ones(nx-l,ny));
V = V-dt*(UVx(:,2:end-l)+V2y);
% implicit viscosity
rhs = reshape(U+Ubc, [],1);
u(peru) = Ru\(Rut\rhs(peru)); %#ok<AGROW>
U = reshape(u,nx-l,ny);
rhs = reshape(V+Vbc, [],1);
v(perv) = Rv\(Rvt\rhs(perv)); %#ok<AGROW>
V = reshape(v,nx,ny-1);
% pressure correction
phia = avg(avg(phi') ');
phia = [phia(end,:);phia;phia(l,:)]; %#ok<AGROW>
curv = curvature(phia,hx,hy);
Cplas = C(:, (nyc-ny)/2+1:(nyc-ny)/2+ny); Cplas =
[Cplas(end,:);Cplas;Cplas(l,:)]; %#ok<AGROW>
stmem = (kmem*(Cplas/(cO2aO/cHb5O_0)).^(-index)).*curv; % stress on
RBC membrane
thetax = abs(phia(2:end-l,:))./(abs(phia(2:end-l,:))+abs(phia(3:end,:)));
thetay = abs(phia(2:end-1,1:end))./(abs(phia(2:end-
1,1:end))+abs(phia(2:end-l,[2:end,end])));
JL = zeros(nx,ny); JR = JL; JB = JL; JT = JL;
for i = 1:nx,
% Jump matrix
ii = i+1;
for j = 2:ny-1,
if sign(phia(ii-l,j)) > sign(phia(ii,j)),
JL(i,j) = JL(i,j) + (thetax(i,j)*stmem(ii-1,j)+(1-
thetax(i,j))*stmem(ii,j))/hx^2;
elseif sign(phia(ii-1,j)) < sign(phia(ii,j)),
JL(i,j) = JL(i,j) - (thetax(i,j)*stmem(ii-1,j)+(1-
thetax(i,j))*stmem(ii,j))/hx^2;
end
if sign(phia(ii+l,j)) > sign(phia(ii,j)),
JR(i,j) = JR(i,j) + (thetax(i,j)*stmem(ii+1,j)+(1-
thetax(i,j))*stmem(ii,j))/hx^2;
elseif sign(phia(ii+1,j)) < sign(phia(ii,j)),
JR(i,j) = JR(i,j) - (thetax(i,j)*stmem(ii+1,j)+(1-
thetax(i,j))*stmem(ii,j))/hx^2;
end
if sign(phia(ii,j-1)) > sign(phia(ii,j)),
JB(i,j) = JB(i,j) + (thetay(i,j)*stmem(ii,j-1)+(1-
thetay(i,j))*stmem(ii,j))/hy^2;
elseif sign(phia(ii,j-1)) < sign(phia(ii,j)),
JB(i,j) = JB(i,j) - (thetay(i,j)*stmem(ii,j-1)+(1-
thetay(i,j))*stmem(ii,j))/hy^2;
end
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if sign(phia(ii,j+1)) > sign(phia(ii,j)),
JT(i,j) = JT(i,j) + (thetay(i,j)*stmem(ii,j+1)+(l-
thetay(i,j))*stmem(ii,j))/hy^2;
elseif sign(phia(ii,j+1)) < sign(phia(ii,j)),
JT(i,j) = JT(i,j) - (thetay(i,j)*stmem(ii,j+l)+(l-
thetay(i,j))*stmem(ii,j))/hy^2;
end
end
end
phia = phia(2:end-1,:);
J = JL+JR+JB+JT;
rhs = (1/dt)*reshape(diff([uW;U;uE],1,1)/hx+diff([vS' V vN'],1,2)/hy +
J, [] , 1);
p(perp) = Rp\(Rpt\rhs(perp)); %#ok<AGROW>
P = reshape(p,nx,ny); P = P+Pgrad;
U = U-dt*diff(P-Pgrad-JL*hx^2-JB*hy^2,1,1)/hx;
V = V-dt*diff((P-Pgrad-JL*hxA2-JB*hyA2),1,2)/hy;
Ue = [uS' avg([uW;U;uE]')' uN']; Ve = [vW;avg([vS' V vN']);vE];
CALCULATE 02 CONCENTRATION USING THE OXYGEN DIFFUSION EQUATION
% calculate velocities at cell center; Hb concentration only inside RBC
Ua = avg(avg(Ue')'); Va = avg(avg(Ve')');
Ua = [zeros(nx, (nyc-ny)/2) Ua zeros(nx, (nyc-ny)/2)]; %#ok<AGROW>
Va = [zeros(nx, (nyc-ny)/2) Va zeros(nx, (nyc-ny)/2)]; %#ok<AGROW>
cHb = cHbconst*ones(nx,ny);cHb(phia>O) = 0;
cHb = [zeros(nx, (nyc-ny)/2) cHb zeros(nx, (nyc-ny)/2)]; %#ok<AGROW>
% calculate hemoglobin saturation
if periodic flag -= 0
SHbx = (SHb([2:end 1],:)-SHb([end 1:end-l],:))/(2*hx);
else
SHbx = [(SHb(2,:)-SHb(l,:))/hx; (SHb(3:end,:)-SHb(l:end-2,:))/(2*hx);
(SHb(end,:)-SHb(end-l,:))/hx];
end
SHby = [zeros(nx,l) (SHb(:,3:end)-SHb(:,l:end-2))/(2*hy) zeros(nx,l);];
rhs = -kinvHb*(SHb-(l-SHb).*(C*(cHb50O_/cHb5O)).^n)*(Dcap/vavg) - Ua.*SHbx
- Va.*SHby;
SHb = (SHb([end 1:end-1],:)+SHb([2:end l],:)+SHb(:,[l 1:end-
l])+SHb(:,[2:end end]))/4 + dt*rhs;
rhs = reshape(SHb, [],1);
shb(pershb) = Rshb\(Rshbt\rhs(pershb)); %#ok<AGROW>
SHb = reshape(shb,nx,nyc);
% calculate myoglobin saturation
if periodic flag -= 0
SMbx = (SMb([2:end l],:)-SMb([end 1:end-l],:))/(2*hx);
else
SMbx = [(SMb(2,:)-SMb(l,:))/hx; (SMb(3:end,:)-SMb(l:end-2,:))/(2*hx);
(SMb(end,:)-SMb(end-1,:))/hx];
end
SMby = [zeros(nx,l) (SMb(:,3:end)-SMb(:,l:end-2))/(2*hy) zeros(nx,l);];
SMby(:,(nyc-ny)/2) = (SMb(:,(nyc-ny)/2)-SMb(:,(nyc-ny)/2-1))/(hy);
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SMby(:, (nyc-ny)/2+ny+1) = (SMb(:, (nyc-ny)/2+ny+2)-SMb(:, (nyc-
ny)/2+ny+1))/hy;
SMby(:, (nyc-ny)/2+1:(nyc-ny)/2+ny) = 0;
rhs = -kinvMb*(SMb-(l-SMb).*C*(cHb5O_0/cMb5O))*(Dcap/Vavg) - Ua.*SMbx -
Va.*SMby;
SMb = (SMb([end 1:end-1],:)+SMb([2:end 1],:)+SMb(:,[l 1:end-
l])+SMb(:, [2:end end]))/4 + dt*rhs;
rhs = reshape(SMb, [1,1);
smb(persmb) = Rsmb\(Rsmbt\rhs(persmb)); %#ok<AGROW>
SMb = reshape(smb,nx,nyc);
% calculate 02 concentration
if periodic flag -= 0
Cx = (C([2:end 1],:)-C([end 1:end-1],:))/(2*hx);
else
Cx = [(C(2,:)-C(1,:))/hx; (C(3:end,:)-C(1:end-2,:))/(2*hx); (C(end,:)-
C(end-1, :))/hx]
end
Cy = [zeros(nx,l) (C(:,3:end)-C(:,1:end-2))/(2*hy) zeros(nx,1);];
% rate of hemoglobin 02 production, myoglobin 02 absorption
RHb = kinvHb*cHb.*(SHb-(1-
SHb).*(C*(cHb50_0/cHb5O)).An)*(Dcap/(cHb5O_0*Vavg));
RMb = kinvMb*cMb.*(SMb-(1-SMb).*C* (cHb50_0/cMb5O))*(Dcap/(cHb5O_0*Vavg));
R = RHb+RMb+M;
rhs = R - Ua.*Cx - Va.*Cy;
C = (C([end 1:end-1],:)+C([2:end l],:)+C(:,[1 1:end-1])+C(:,[2:end
end]))/4 + dt*rhs;
rhs = reshape(C,[],1);
c(perc) = Rc\(Rct\rhs(perc)); %#ok<AGROW>
c(c<0) = 0; %#ok<AGROW>
C = reshape(c,nx,nyc);
% VISUALIZATION
if floor(25*k/nt)>floor(25* (k-i)/nt),
fprintf('.')
end
if k==l||floor(nsteps*k/nt)>floor(nsteps* (k-1)/nt)
t sec = round(k*dt);
eval(['save Data\MicroData_',num2str(tsec),'.mat x y yc Ue Ve C P phi
st mem']);
figure(1), contourf(x,y,-phi', [0 0],k-');hold on;
contour(x,y,Ue',20);colorbar;caxis([O 31);hold off;
title(sprintf('U at t=%0.2f',tsec));xlabel('x');ylabel('y');
saveas(figure(l), ['Data\U_ ',num2str(tsec)],'fig');saveas(figure(1), ['Data\U_
',num2str(tsec)],'png');
figure(2), contourf(x,y,-phi', [0 0],'k-');hold on;
contour(x,y,Ve',20);colorbar;caxis([-0.05 0.05]);hold off;
title(sprintf('V at t=%0.2f',tsec));xlabel('x');ylabel('y');
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saveas(figure(2), ['Data\V_ ',num2str(t sec)], 'fig');saveas(figure(2), ['Data\V_
',num2str(tsec)],'png');
figure(3), contourf(avg(x),avg(y),P',20,'w-');hold on;
Len = sqrt(Ue.^2+Ve.^2+eps);
quiver(x,y, (Ue./Len)', (Ve./Len)',.4,'k-');
hold off, axis equal, axis(ax), colorbar;
p = sort(reshape(P,1, [])); caxis(p([8 end-7]));
title(sprintf('Re = %O.lg t =
%0.2f',Re,tsec));xlabel('x');ylabel('y');
saveas(figure(3), ['Data\P_ ',num2str(tsec)], 'fig');saveas(figure(3), ['Data\P_
',num2str(tsec)],'png');
figure(4), contourf(x,y,-phi', [0 0],'k-');hold on;
[-,hl=contour(avg(x),avg(yc),C',0:0.25:4);colorbar;caxis([O 4]);axis
equal,axis(axc);hold off;
set(h,'ShowText','on', 'TextStep',get(h,'LevelStep')*2);
title(sprintf('O 2 Concentration and RBC geometry at
t=%0o.2f',t-sec));xlabel('x');ylabel('y');
saveas(figure(4), ['Data\C_ ',num2str(t sec)], 'fig');saveas(figure(4), ['Data\C_
',num2str(tsec)],'png');
drawnow;
end
% boundary conditions
uE = mean([U(1,:);U(end,:)]); uW = uE;
VE = [(vN(1)+vN(end))/2 mean([V(1,:);V(end,:)]) (vS(1)+vS(end))/2]; vW =
VE;
if periodic flag ~ 0
C(1,:) = C(end,:);
else
C(1,:) = (cO2a/cHb500); C(end,:) = (cO2v/cHb50 0);
end
end
fprintf(['\nRBC Volume Retained = ',num2str(100*volf f/volf 0),'%% \n']);
fprintf(['\nlevel-set shifted down ',num2str(-num shift1),' times and shifted
up ',num2str(numshifto),' times by ',...
num2str(hxf*hyf),' units in ',num2str(tf),' seconds\n']);
function B = avg(A,k)
if nargin<2,
k = 1;
end
if size(A,1)==1,
A = A';
end
if k<2,
B = (A(2:end,:)+A(1:end-1,:))/2;
else
B = avg(A,k-1);
end
if size(A,2)==1,
B = B';
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end
function A = Kl(n,h,all)
% all: Neumann=l, Dirichlet=2, Dirichlet mid=3, Periodic = 10;
if all == 10,
A = (spdiags(ones(n,l)*[-l 2 -1],-1:1,n,n) + spdiags(ones(n,1)*[l 1], [-
n+l n-1] ,n,n) )/h^2;
else
A = spdiags([-l all 0;ones(n-2,1)*[-l 2 -1];0 all -l],-l:l,n,n)'/hA2;
end
function F = curvature(P,hx,hy)
% computes curvature by central differences
Pxx = diff(P([l 1:end end],:),2,1)/hxA2;
Pyy = diff(P(:,[l 1:end end]),2,2)/hy^2;
Px = (P([2:end l],:)-P([end 1:end-l],:))/(2*hx); %periodic along x;
Py = (P(:,3:end)-P(:,l:end-2))/(2*hy); Py = Py(:,[l 1:end end]);
Pxy = (Px(:,3:end)-Px(:,l:end-2))/(hx+hy); Pxy = Pxy(:,I[l 1:end end]);
F = (Pxx.*Py.A2-2*Px.*Py.*Pxy+Pyy.*Px.A2)./(Px.A2+Py.A2).A.5;
F = min(max(F,-l/(0.5*(hx+hy))),l/(0.5*(hx+hy)));
function dP = FabsgradP(P,h,F,c)
% level-set update function
if nargin<4,
c = 0;
if nargin<3,
F = 1;
end
end
DxP = diff(P,1,1)/h; DxmP = DxP([l 1:end],:); DxpP = DxP([l:end end),:);
DyP = diff(P,1,2)/h; DymP = DyP(:,[l 1:end]); DypP = DyP(:,[l:end end]);
Np = sqrt(max(DxmP,O) .2+min(DxpP,O) .2+max(DymP,0).A2+min(DypP,0).^2);
Nm = sqrt(min(DxmP,0) .2+max(DxpP,0) .2+min(DymP,0) .^2+max(DypP,O).^2);
dP = max(F,0).*(Np-c)+min(F,O).*(Nm-c);
function SHb = Hb_Sat(PO2_pa,pHbSOpa,n)
P02 = PO2_pa/133.322368; pHb5O = pHb50_pa/133.322368; % Pa -- > torr
SHb = (P02.An)./(pHb5OAn+P02.An);
142
References
[1] Platt, 0. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, 0.,
Steinberg, M. H., Klug, P. P. (1994). Mortality In Sickle Cell Disease -- Life
Expectancy and Risk Factors for Early Death. New England Journal of
Medicine. 330(23): 1639-1644.
[ 2 ] Eppolito, Amanda. (2005). The Physiology of Sickle Cell Anemia. Davidson
College.
http://www.bio.davidson.edu/people/midorcas/animalphysiology/websites
/2005/Eppolito/intro.htm.
[3 1 Friedman, Milton J. (1978). Erythrocytic mechanism of sickle cell resistance
to malaria. Proc. Nati. Acad. Sci. USA, 75(4): 1994-1997.
[ 41 Secomb, T. W., Hsu, R., and Pries, A. R. (2006). Tribology of capillary blood
flow. Proc. IMechE, Part J: Engineering Tribology, 220: 767-774.
[5 1 Dou, Q., Ferrone, F. A. (1993). Simulated Formation of Polymer Domains in
Sickle Hemoglobin. Biophysical J., 65: 2068-2077.
[ 61 Cokic, V. P., Smith, R. D., Beleslin-Cokic, B. B., Njoroge, J. M., Miller, J. L.,
Gladwin, M. T., and Schechter, A. N. (2003). Hydroxyurea induces fetal
hemoglobin by the nitric oxide-dependent activation of soluble guanylyl
cyclase. J. Clin. Invest. 111(2): 231-239.
[7 1 Information Center for Sickle Cell and Thalassemic Disorders. (2002).
http://sickle.bwh.harvard.edu/hbsynthesis.html.
[ 8 1 Le Floch-Yin, Francois T. (2010). Design of a Numerical Model for
Simulation of Blood Microcirculation and Sickle Cell Disease. (Ph.D. thesis -
Dept. of Aeronautics and Astronautics). Massachusetts Institute of
Technology, MA.
[ 91 Berne, R. M., Levy, M. N., Koeppen, B. M., Stanton, B. A. (2004).
PHYSIOLOGY. Fifth Edition. Elsevier, Inc. Mosby; St. Louis, MO. Chap. 18-20.
[10 1 Mark, Roger G. (2004). Introduction: The Functional Anatomy of the
Cardiovascular System. HST542J: Quantative Physiology: Organ Transport
Systems. Harvard-MIT Division of Health Sciences and Technology.
[11 1 Franklin Institute. http://www.fi.edu/learn/heart/blood/blood.html
[12 1 Vadapalli, A., Goldman, D., and Popel, A. S. (2002). Calculations of Oxygen
Transport by Red Blood Cells and Hemoglobin Solutions in Capillaries. Art.
Cells, Blood Subs., and Immob. Biotech., 30(3): 157-188.
[13 1 Seibold, B. (2008). A compact and fast Matlab code solving the
incompressible Navier-Stokes equations on rectangular domains:
143
mit18086_navierstokes.m. Applied Mathematics, Massachusetts Institute of
Technology. (http://www-math.mit.edu/cse/).
[ 14 ] Osher, S., Sethian, J. A. (1988). Fronts propagating with curvature-
dependent speed: algorithms based on Hamilton-Jacobi formulations. Journal
of Computational Physics. Vol. 79: 12-49.
[15 ] Crank, J.; Nicolson, P. (1947). A practical methodfor numerical evaluation
of solutions of partial differential equations of the heat conduction type. Proc.
Camb. Phil. Soc. 43 (1): 50-67.
[ 16] Rand, R. P., Burton, A. C. (1964). Mechanical Properties of the Red Cell
Membrane: L Membrane Stiffness and Intracellular Pressure. Biophysical J.,
4(2): 115-135.
[17 ] Berger, S. A., and King, W. S. (1980). The Flow of Sickle Cell Blood in the
Capillaries. Biophysical J., 29(1): 119-148.
[18] Usami, S., Chien, S., Bertles, J. F. (1975). Deformability of Sickle Cells as
Studied by Microsieving. J. Lab. Clin. Med., 86: 247-279.
[19] Winslow, R. M. (1976). Blood Oxygen Equilibrium Studies in Sickle Cell
Anemia. In Proceedings of the Symposium on Molecular and Cellular Aspects
of Sickle Cell Disease. J. I. Hercules et al., editors. National Heart, Lung, and
Blood Institute, Bethesda, Md. (DHEW Publ. No. (NIH) 76-1007). 235.
144
